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 Growing evidence has indicated that typical RNA viruses can persist, which 
might be responsible for affinity maturation of antibody, life-long immunity, and post-
viral autoimmune diseases. 
 Sindbis virus (SINV) has been known to persist in mouse CNS with 3 phases of 
clearance; 1
st
 – rapid clearance of infectious virus within 7-8 days, 2
nd
 – gradual 
clearance of SINV RNA during 7-60 days, and 3
rd
 – sustained low-level SINV RNA after 
60 days. My study characterized the nature of SINV persistence and tested the role of 
immunoglobulin classes in SINV clearance. We intracerebrally inoculated a low 
neurovirulent SINV TE strain into immunoglobulin-deficient mice, which are AID-/- 
(IgM only), sIgM-/- (no IgM), and double knockout (DKO, no antibody) mice, compared 
to wild-type (WT) mice. 
In the 1
st
 phase, RNA FISH and immunofluorescence (IF) showed an abundance 
of all viral components, which are genomic RNA, subgenomic RNA, dsRNA, nsP3, 
capsid, E2, 6K, and E1. Long-range RT-PCR showed intact genomic RNA. DKO mice 
cleared infectious virus from the spinal cord, but not from the brain. AID-/- and sIgM-/- 




 phase, the viral components that persisted were mainly SINV 
subgenomic RNA and capsid protein. SINV genomic RNA was completely undetectable, 
and the subgenomic RNA had large deletions in the E2-E1 genes. Only DKO mice had 
 iii 
infectious virus reactivated in this phase. There was no difference in viral RNA clearance 
from both brains and spinal cords, detected by RT-qPCR, between 4 mouse groups. 
In the 3
rd
 phase, DKO mice sustained higher levels of viral RNA in both the brain 
and spinal cord than other groups. DKO mice also still had infectious virus in the brain.  
 Using SINV with fluorescent RNA aptamers, we demonstrated in live-cell 
imaging that antibody treatment cleared SINV RNA from differentiated neurons, except 
for a few cells without bound antibody.  
 In conclusion, SINV RNA persists primarily in a form of incomplete subgenomic 
RNA. Loss of the E2 gene prevents anti-E2 antibody binding, and may facilitate 
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Introduction to Sindbis Viral Encephalomyelitis 
Sindbis virus (SINV) was first isolated in 1952 from a group of mosquitoes, 
captured in the Egyptian village, after which the virus was named (1). In humans, SINV 
causes fever, rash, and arthritis; also known as Ockelbo disease in Sweden, Pogosta 
disease in Finland, and Karelian fever in Russia (2-4).  
SINV is an alphavirus in Togaviridae family. New world alphaviruses (e.g. 
Western, Eastern, and Venezuelan equine encephalitis viruses) cause encephalitis. Old 
world alphaviruses (e.g. Chikungunya and Sindbis viruses) mainly cause rash and 
arthritis (5), but still have potential to induce encephalitis in some cases (6, 7). 
Epidemiology 
 SINV infection is a mosquito-borne disease. SINV is usually circulated between 
birds and mosquitoes, but sometimes humans and domestic mammals can become 
incidental hosts from mosquito bites (5). Human cases have been reported from northern 
Europe, Africa, China, and Australia, with annual incidence from 2 to 6.6/100,000 and 
average seroprevalence of about 5% in middle-aged populations (8).  
Virus structure 
 SINV is an enveloped virus, 70 nm in diameter. Its nucleocapsid core consists of 
11.7 kb positive-sense single-stranded genomic RNA with 5’ cap and 3’ poly-A tail in an 
icosahedral capsid (240 monomers). Its envelope is derived from the host plasma 
membrane and includes 80 trimers of E1 and E2 glycoprotein heterodimers (8). 
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Life cycle (Figure 1.1) 
 Virus entry 
 SINV utilizes various surface molecules in a wide-range of host cells (mammals, 
insects, birds) as a receptor for E2 glycoprotein attachment. Examples of these SINV 
receptors are laminin receptor, DC-SIGN, L-SIGN, heparan sulfate, and natural 
resistance-associated macrophage protein (NRAMP) (9). Upon binding, the virion is 
endocytosed. Exposure to low pH in the endosome triggers conformational change of 
envelope proteins and membrane fusion by E1 glycoprotein. The nucleocapsid core is 
released and disassembled, releasing its genomic RNA into cytoplasm (5).  
 Viral RNA replication (Figure 1.2) 
The 49S genomic RNA is translated into nonstructural polyproteins P123 and 
readthrough translated into P1234. Uncleaved P123 and nsP4 preferably replicate the 
minus strand in the early phase. Later, nsP2, which has proteolytic activity, cleaves the 
polyprotein into nsP1, nsP2, and nsP3. With the cleaved nsP1-4, the viral replication is 
shifted from minus to plus strands, which are 49S genomic and 26S subgenomic viral 
RNA (10, 11).  
 Functions of nonstructural proteins (nsP) 
nsP1 functions as a methyltransferase and guanyltransferase, essential for 5’ 
capping of viral genomic and subgenomic RNAs. nsP1 also limits proteinase activity of 
nsP2. The N-terminal domain of nsP2 is an RNA helicase, while the C-terminal domain 
is a proteinase, responsible for the cleavage of the nonstructural polyproteins. The 
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functions of nsP3 are not well defined, but are involved in formation of the replication 
complex and its internalization that forms the type I cytopathic vacuoles (see below). 
nsP4 is the RNA polymerase (11). 
 Virus assembly and budding 
The 26S subgenomic RNA is translated into the structural polyproteins, capsid-
E3-E2-6K-E1 and capsid-E3-E2-Transframe. Instead of 6K, the latter has transframe 
(TF), which is the result of C-terminal extension by ribosomal frameshifting (-1 open 
reading frame). Both 6K and TF mainly affect the efficacy of viral budding (12). The 
capsid cleaves itself from the polyprotein and encapsidates the viral genome, forming a 
nucleocapsid. The rest of polyproteins accumulate in the endoplasmic reticulum (ER) 
membrane and are cleaved into E1 and pE2 by signal peptidase. The envelope proteins 
are glycosylated in the Golgi apparatus and are matured upon transportation to the plasma 
membrane by cellular furin cleavage of pE2 into E2 and E3. The cytoplasmic tail of E2 
interacts with a hydrophobic pocket in the capsid on the nucleocapsid, leading to 
assembly and budding of infectious virus (11). 
Cytopathic vacuoles (CPV) (Figure 1.3) 
Sindbis virus forms 2 types of cytopathic vacuoles (CPV), spherule-containing 
CPV-I and nucleocapsid-surrounded CPV-II; single-membrane vacuoles derived from 
late endosome and trans-Golgi network (TGN), respectively (13-15). One report claimed 
that there is another type of a spherule-containing vacuole, which has double membranes 
and is possibly derived from the mitochondrion (14). 
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Formation of alphavirus replication complexes and CPVs (Figure 1.4)  
After clathrin-mediated endocytosis, the drop in pH induces fusion and the viral 
nucleocapsid is released. Viral RNA is translated into nonstructural proteins (nsP1-4), 
and the viral RNA-nsPs complex is transported to cell membrane where it forms a site of 
viral RNA synthesis (replication complex) (13, 16) in a 50-nm single membranous 
spherule, protruding outside of the cell (16, 17). Internalization of the spherules on the 
plasma membrane is mediated by actin-myosin (inhibited by blebbistatin) and PI3K 
(inhibited by wortmannin). These spherule-containing vesicles fuse with each other and 
with a late endolysosome (inhibited by nocodazole) to form an acidic large (600-2000 
nm) cytopathic vacuole type I (CPV-I), which is transported by microtubules (inhibited 
by nocodazole) to the perinuclear area (17, 18). The spherules are inside and line the 
inner surface of CPV-I. The cytoplasm is connected to the inside of the spherule through 
a pore, 5-10 nm in inner and 19-20 in outer diameter (16, 17). 
Interestingly, internalization of replication complexes in a spherule is not a 
universal phenomenon for alphaviruses. Internalization can be found in SINV and 
Semliki Forest virus (SFV), but not in Chikungunya virus (19, 20). This process requires 
PI3K activation, mediated by a hyperphosphorylated/acidic domain in the hypervariable 
c-terminal tail of nsP3, and can be inhibited by wortmannin, a PI3K inhibitor. A 
recombinant Chikungunya virus with the hypervariable c-terminal tail of nsP3 from SFV 




Sindbis viral encephalomyelitis in mice 
SINV can cause encephalitis in mice. If the mice survive, there are 3 phases of 
SINV clearance; 1
st
 – rapid infectious viral clearance (day 5-8), 2
nd
 – gradual viral RNA 
clearance (week 2-8), and 3
rd
 – sustained low level of viral RNA (after 8 weeks) (Figure 
1.5A) (21). 
In vivo imaging of mice infected with SINV-luciferase shows the steps of virus 
spread from first to last; the inoculated foot pad, the popliteal lymph node, the blood, the 
nasal mucosa, the brain, and the spinal cord (22).  
Outcome determinants 
The outcomes of mice with Sindbis encephalitis mainly depend on route of 
infection (23), strains of SINV, genetic background of mice, age of mice (Table 1.1) (24-
26). Mature neurons are more resistant to apoptosis and the interferon response is primed, 
leading to better survival of adult mice than young mice with more immature neurons 
(27). For instance, compared to immature neurons (cAP7), interferon regulatory factor 
(IRF)-3 and IRF-7 are upregulated in differentiated rat olfactory neurons (dAP7). cAP7 
cells express the short γ-isoform of IRF-7, but dAP7 cells express long active α-isoform. 
Nevertheless, RNA silencing of IRF-3 and IRF-7 does not improve the viral replication in 
dAP7 cells (28). Other neuronal cell lines, CSM14.1 (rat nigral cell) and NSC34 (mouse 
motor neuron), when differentiated, resist and survive SINV infections better than 
undifferentiated cells (29). Furthermore, adult mice express much higher levels of ISG12  
(interferon stimulated gene). Newborn pups, infected with recombinant SINV-ISG12, 
have better outcomes than pups infected with control SINV (30).  
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BALB/c mice are resistant to fatal encephalitis from neuroadapted Sindbis virus 
(NSV). Their infected brains have a higher number of regulatory T-cell producing IL-10 
and a lower number of Th17 than susceptible C57BL/6 mice. BALB/c mice that lack IL-
10 will succumb to the fatal encephalitis (31). One genetic determinant for control of 
viral replication and outcome is mapped to chromosome 2, but the gene has not been 
identified (32).
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Table 1.1 Summary of commonly used SINV strains (24-26) 




Egypt, 1952 (1) 






weanling mice (33) 
E2 from NSV 
E1 from SV1A 





E2 – Q55H, R209G 
E1 – V72A, G313D 
E2 – Q55H, R209G 
Mortality in 
suckling mice 
100% 100% 100% 
Mortality in 
weanling mice 
0% 100% 4% 
Mortality in adult 
mice 
0% 
0% - BALB/c     
100% - C57BL/6 
0% 
Encephalitis model - 
Immune-mediated 
pathology, prevention 






Innate immune responses.  
 Generally, the initial response to infection begins when pattern recognition 
receptors (PRR – e.g. toll-like receptors (TLR), protein kinase R (PKR), etc.) interact 
with viral pathogen-associated molecular patterns (PAMP – e.g. dsRNA), resulting in the 
production of IFN-α/β. IFN-α/β activates interferon-stimulated genes (ISG) to produce 
proteins, which have antiviral effects (34). 
 TLR3-/- and MyD88-/- (myeloid differentiation primary response) mice do not 
differ from WT C57BL/6 in term of infectious virus clearance, IFN-α production, and 
mortality from NSV infection. IRF7-/- mice fail to generate type-I IFN, are more 
susceptible to fatal encephalitis, and have higher titers of infectious virus than WT mice. 
Unc93b1
3d/3d 
mice cannot transport TLR3, TLR7, and TLR9 from endoplasmic reticulum 
(ER) to their functional sites in the endosome. They die earlier and have higher amount of 
infectious virus, but still produce the same level of IFN-α as WT mice after NSV 
infection (35). TLR7 has not been studied in SINV encephalitis yet, but plays important 
role in a mouse model of Ross River virus (RRV)-induced myositis/arthritis. TLR7-/- 
mice have worse outcomes, higher RRV viral loads, and produce only low affinity 
antibody (36). 
 Mitochondrial antiviral-signaling protein (MAVS or IPS-1) is an intermediary 
protein for both MDA-5 and RIG-I, which can detect viral RNA in the cytosol. IPS-1-/- 
mice have worse outcomes and higher levels of both infectious virus and viral RNA. A 
mutation in nsP1 that attenuates viral neurovirulence leads to a better interaction with 
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MAVS (37). PKR, Mx-1, and RNase L have antiviral properties, but are not essential for 
SINV clearance from the CNS (38). 
SINV Toto 1101 (low virulence, only 50% mortality in suckling mice) inoculation 
can kill all A129 mice, which lack the IFN-α/β receptor. Expression of ISG15 (interferon-
stimulated gene 15), a ubiquitin homolog, can partially rescue mice that lack IFN-α/β 
receptor (39). ISG15-/- mice also have higher mortality rates than WT mice (40). The 
expression of zinc-finger antiviral protein (ZAP), another IFN-inducible factor, can 
destabilize viral RNA and rescue cells that lack type I interferon from SINV infection. 
ZAP-deficient mice are also very susceptible to SINV infection (41). STAT1 is needed 
for IFN-α, β, and γ responses. STAT1-deficient C57BL/6 mice, infected with the same 
strain of SINV, die even faster than A129 mice (23, 42). On the other hand, SINV TE 
inoculation does not kill IFN-β-deficient C57BL/6 mice. These mice have higher titer of 
infectious virus at the peak (day 3), but can clear the virus similarly to WT mice (43).  
SINV nsP2 is thought to be involved in host transcription and translation shut-off, 
leading to the suppression of IFN-stimulated gene (ISG) induction (44). 
Adaptive immune response 
 SINV-specific T and B cells, induced in the draining cervical lymph nodes, 
infiltrate foci of infection in the mouse CNS in this order; CD8 T-cells, CD4 T-cells, 
IgM-B-cells, and then IgG/A-B-cells (Figure 1.5B) (21). The main adaptive immune 
cells in the first phase of infectious viral clearance are CD8 T-cells, and IgM-producing 
plasmablasts, while CD4 T cells and IgG-producing plasmablasts are more prominent in 
the second phase of clearance of viral RNA . 
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T-cells 
 Both CD4 and CD8 T-cell depletion affects clearance of SINV. In μMT mice (no 
antibody production), depletion of both CD4 and CD8 T-cells results in similar levels of 
persistent virus as in severe combined immunodeficiency (SCID) mice in both the brain 
and the spinal cord. SINV-specific T-cell transfer reduces infectious virus from the brain 
and clears infectious virus from the spinal cord of persistently infected recombination 
activating gene-1 knockout (RAG-/-) mice (45).  
 IL-10 produced by regulatory T-cells (Treg) is an important regulatory cytokine. 
Although IL-10 knock out mice clear SINV normally, they develop symptoms earlier and 
have worse outcomes, most likely due to the increase of pathogenic Th17 cells in the 
CNS (46). 
Interferon-gamma (IFN-γ)  
The main T-cell cytokine that helps clear SINV from the CNS is IFN-γ. In SCID 
mice, infection with recombinant SINV TEdsIFN-γ, in which infected cells produce IFN-
γ reduces infectious virus in brains and clears virus from spinal cords similar to μMT 
mice, while SINV TEdsTNF-α infection increases the titer of infectious virus (45). IFN-γ 
deficient and IFN-γ-receptor 1 deficient mice clear infectious virus from brains similarly 
to WT mice, but have delayed clearance from spinal cords (43, 47). 
In differentiated neuronal cells, CSM14.1 (rat nigral cell line), IFN-γ pretreatment 
limits SINV replication, while treatment at 24 hours post infection helps clear the virus 
and improves survival. IFN-γ treatment suppresses synthesis of viral RNA and proteins, 
and restores host protein synthesis (29). IFN-γ treatment also inhibits SINV replication in 
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differentiated NSC34, AP7, and mouse primary dorsal root ganglion neurons (29, 48). 
The antiviral and neuroprotective abilities of IFN-γ depend on JAK/STAT signaling (48).   
B-cells 
 μMT mice that lack B cells and antibody can clear infectious SINV from spinal 
cords but not from brains (43). 
 In WT mice, prolonged up-regulation of CXCL9, CXCL10, CCL1, CCL2, and 
CCL5 chemokine production in the CNS recruits B-cells that express chemokine 
receptors – CXCR3, CXCR5, and CCR7. B-cell activating factor (BAFF) produced in the 
CNS may help in retention of these cells (49, 50). BrdU labeling indicates that infiltrating 
B-cell mainly originate from the early germinal center response in cervical lymph nodes 
and continue to proliferate in the CNS(50). At late time points, most B-cells in the brain 
are plasmablasts with few plasma cells and memory B-cells. An increase in IgA-secreting 
cells in CNS but not in the blood suggests on-going class-switching in the CNS without 
evidence of affinity maturation of antibody or extranodal germinal centers (50, 51). 
Antibody 
 See details in Chapter 3. 
Differential clearance of virus from CNS 
 Components of the immune response required for viral clearance are dependent 
on viral strains, the types of cells, and organs infected. For example, antibody is needed 
for mouse hepatitis virus (MHV) clearance from both brain and spinal cord, but not from 
liver (52). Mice immunized with vesicular stomatitis virus (VSV) can interact with cells 
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expressing VSV nucleoprotein and clear recombinant vaccinia virus in bystander cells in 
the brain, but not in testes or ovaries, by T-cell dependent IFN-γ production (53). 
 In SINV encephalomyelitis, viral clearance from brain is different from viral 
clearance from spinal cords. Antibody and IFN-γ are effective and synergistic in 
clearance of SINV from both brain and spinal cord. In brains, antibody can fully 
compensate for a lack of IFN-γ, but IFN-γ cannot compensate for the lack of antibody 
(Figure 1.6). In spinal cords, both can compensate for the lack of each other with only 
some delay in clearance (43, 47) (Table 1.2). 
Table 1.2 Comparison between brain (B) and spinal cord (S) SINV clearance by antibody 
and IFN-γ (43, 47) 
 Antibody+ Antibody- 
IFN-γ+ B: normal  
S: normal 
B: persistent (low level) 
S: short delayed 
IFN-γ- B: normal 
S: short delayed 
B: persistent 
S: persistent (low level) 
 
Unsolved questions 
 Though many previous studies have shown that Sindbis viral RNA can persist for 
a long period of time, very little is known about the nature of this persistence especially 
after the clearance of infectious virus. Where does the virus hide? How can the virus 
persist? We address these questions in Chapter 2 of this thesis. 
 13 
 Antibody is arguably the most powerful in viral clearance. It can protect mice 
even in some of the worst combinations between virus strains and hosts. Antibody-
mediated non-cytolytic clearance does not require the Fc portion of the antibody, 
interferon, complement, or immune cells. How antibody clears intracellular viral RNA 
without killing the cells is still largely unknown. To bring some insight into this topic, we 
produced recombinant Sindbis virus that has fluorescent RNA aptamers in Chapter 4. 
This makes real-time observation of viral RNA replication and clearance in live cells 
possible. Most of anti-SINV antibodies tested for clearance in vitro and in vivo have been 
IgGs, but the fact that only IgM-secreting cells are present in mouse CNS during the 













Figure 1.2 SINV genome and its replication strategy (11) 
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Figure 1.3 A – Replication complex-containing 
spherules on plasma membrane at early infection.  
B – CPV-I with spherules inside at late infection (20). C 
– CPV-II with envelope proteins inside and surrounded 





Figure 1.4 Formation of replication complex and CPV-I in alphavirus (18). RC – 
replication complex, PM – plasma membrane, SFV – Semliki Forest virus, LE – late 
endosome, wort – wortmannin, CPV-I – cytopathic vacuole type I, pink color – acidity.  
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Figure 1.4 Spread of SINV from the periphery into the CNS (22). (Subcu – subcutaneous 
tissue, LN – lymph node) 
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Figure 1.5 A – Clearance of Sindbis infectious virus and viral RNA, B – Immune cell 
infiltration into brains after SINV infection (21). 
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Figure 1.6 Clearance of infectious Sindbis virus from mouse brains (21, 43) (GKO – 
IFN-γ knock out, BKO – IFN-β knock out, WT B6 – wild type C57BL/6, SCID – severe 




Sindbis Viral Persistence in Central Nervous System 
Introduction: 
 Viral persistence and/or latency are well known among DNA viruses, retroviruses, 
and RNA viruses that cause chronic infection like hepatitis C virus (54) and lymphocytic 
choriomeningitis virus (55). However, typical RNA viruses mostly cause acute infections. 
These include influenza, measles, rubella, mumps, dengue, rhinovirus, etc. Hosts usually 
recover and presumably eradicate the viruses completely from their bodies within 1 or 2 
weeks. This assumption might be false, since there have been growing evidences of viral 
persistence by these RNA viruses. 
Indirect evidence 
 Many RNA viral infections can cause life-long immunity. Some of them have 
been eradicated or a very low incidence in particular areas, making immunity boosting by 
re-infection unlikely. Viral persistence, if true, could be a source of endogenous boosting.  
One of the well-known aspects of the immune response, the affinity maturation of 
antibody, is an antigen-driven process. For example, in SARS (severe acute respiratory 
syndrome) -associated coronavirus, it takes 3 months after acute viral infection to reach 
maximum affinity (56). By the time infectious virions have been cleared, 1-2 weeks after 
infection, low-affinity virus-specific antibody has just appeared. Thus, we may infer that, 
after the host’s recovery and clearance of infectious virions, viral antigens at least still 
persist in hosts for months; otherwise, affinity maturation cannot happen. 
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Direct evidence 
 Most direct evidence of persistence relies on reverse transcription polymerase 
chain reaction (RT-PCR) detection of specific viral RNA. Following are some examples 
of persistence of RNA viruses that typically cause acute infections, followed by rapid 
clearance of infectious virions from hosts. 
 Humans 
 West Nile viral RNA was found in 20% of urine samples up to 6 years after 
infection (57). 
 Dengue viral RNA was found in 7% of bone marrow aspirations (58), 8% of 
lymphoid tissues (59), and 14% of kidneys (60) in Thai patients that had 
elective surgeries or procedures without clinical sign of infection. Paired sera 
for anti-dengue ELISA (enzyme-linked immunosorbent assay) before and 
after tissue collections confirmed no acute or recent infection in these patients. 
They most likely acquired dengue infection many years earlier because the 
dengue virus seroprevalence is 95% in Thai young adults (61). 
 Rubella virus and antigen were found in 85% of peripheral blood lymphocytes 
from patients with rubella-associated arthritis up to 6 years after infection (62). 
 Measles viral RNA was found in many sites, including blood, respiratory 
secretion, urine, and lymphoid tissues, up to 3 months in children after 
infection. It can also establish persistent infection in neurons and cause 




 Measles viral RNA was found in peripheral blood mononuclear cells 
(PBMC), nasal swabs, and lymph nodes of rhesus macaques up to 6 
months after infection (64). 
 Coxsackie viral RNA was found in mouse brains up to 3 months after 
infection, while chronic inflammation was observed in brains up to 9 
months (65). 
 Sindbis viral RNA was found in mouse brains up to 17 months after 
infection (66). 
Persistence of Sindbis virus in a mouse encephalitis model 
Neurons can host many kinds of viral persistence and latency. Non-fatal 
neurotropic Sindbis (TE strain) viral RNA persistence can be detected in mouse brains. 
Though infectious virus is cleared within the first week after infection, the clearance of 
viral RNA is much slower. After 8 weeks, the viral RNA level reaches its nadir and is 
maintained at a low level for the lifespan of the mouse (21). However, the distribution, 
cell types, and viral components of persistent virus after acute infection have not been 
elucidated. 
Materials and Methods: 
Sindbis virus TE strain preparation 
BHK cells were cultured in a T150 flask at 37
O
C 5% CO2 in Dulbecco’s Modified 
Eagle Medium (DMEM, Gibco) with 10% heat-inactivated fetal bovine serum (FBS), 1% 
PenStrep (PS, Gibco), and 2mM glutamine (Gibco). When cells were nearly confluent, 
 24 
the media were replaced, after phosphate buffer saline (PBS) wash, with 5 ml of infection 
medium (DMEM, 1%FBS, 1%PS, 1%glutamine) containing recombinant TE virus (see 
details of in vitro transcription and transfection in Chapter 4) at a multiplicity of infection 
(MOI) of 2. After 1 hour of incubation at 37
O
C 5% CO2 with rocking every 20 minutes, 
10 ml of DMEM with 1% FBS was added for another 3 hours of incubation. All medium 
was then replaced with 15 ml of fresh DMEM with 1%FBS. After overnight incubation at 
37
O
C 5% CO2, the supernatant fluid was collected and centrifuged at 2000 rpm for 5 
minutes (Sorvall) to eliminate cell debris. The supernatant fluid was aliquoted; the 
infectious virion number determined by plaque assay (see Chapter 3), and stored at -
80
O
C. The TE stock used for all experiments had a titer of 2.63 X 10
9
 plaque forming 
units (pfu)/ml. 
For purification, 1/3 volume of 40% polyethylene glycol (PEG8000, Sigma) with 
2 M NaCl (Sigma) was added to virus-containing supernatant fluid. The mixture was 
incubated at 4
O
C overnight on a rocker. The PEG precipitate was spun down at 10,000 
rpm for 1 hour (Sorvall). Supernatant fluid was removed and the precipitate was 
resuspended in PBS. This concentrated virus was used directly for ELISA plate coating 
and gave a very low background. Thus, further sucrose gradient purification was not 




Infected BHK cells could also be collected and used as infected cell lysate for 
ELISA plate coating. Using a cell scraper, cells were collected in cold PBS and 
centrifuged at 2000 rpm for 5 minutes (Sorvall). The cell pellet was resuspended in 1 ml 
of PBS with 0.05% Tween-20. Three freeze (-80
O
C)-thaw (on ice) cycles were done to 
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lyse the cells. After centrifugation at 2000 rpm 4
O
C for 20 minutes, the lysate 
(supernatant) was aliquoted and stored at -80
O
C. 
Mouse infection and tissue collection 
 C57BL/6 mice of both sexes, 4-6 weeks old, were inoculated with 20 μl of PBS, 
containing Sindbis virus TE strain from infected BHK cells either 10
3
 pfu for 
intracerebral infection by an insulin syringe or 10
5
 pfu for intranasal infection by a pipette 
under isoflurane anesthesia.  
On planned dates after infection, the mice were euthanized under isoflurane 
anesthesia. Intracardiac perfusion with 15-20 ml of ice-cold PBS was followed by 40 ml 
of ice-cold 4% paraformaldehyde (PFA powder, Sigma) in PBS (final pH7.2). Each brain 
was sliced into 2-3 mm thickness with a razor and immersed in ice-cold 4% PFA 
overnight at 4
O
C. The PFA was then replaced with ice-cold PBS before the brain slices 
were sent to the Johns Hopkins Pathology Reference Laboratory. In the experiment 2 
(below), the 4% PFA perfusion step was omitted, because the left brain hemisphere was 
used for plaque assay, which required live virus. For spinal cord, the whole spinal column 
was collected and processed in the same way plus a decalcification step. 
Tissue handling and staining 
Formalin-fixed paraffin-embedded (FFPE) mouse brains and spinal cords. 
The embedding, 5-μm sectioning, and mounting of the tissues on positively charged 
slides was done by Johns Hopkins Pathology Reference Laboratory. The tissues came 
from 3 independent experiments: 
 26 
1. Previous study by Talibah Metcalf (50) – mice were intracerebrally inoculated 
and sacrificed for FFPE with collection of whole brains and spinal cords on days 
7, 10, 14, 26, 120, and 180. For each time point, there were 3 infected mice and 2 
mock-infected mice (injected with PBS only). Day 3 was added later to represent 
the peak of infection. 
2. The current study (Chapter 3) – mice were intracerebrally inoculated and 
sacrificed for FFPE of right brain hemispheres on days 0, 1, 2, 3, 5, 7, 10, 14, 21, 
30, 45, 60, 90, and 180. There were 3 mice per each time point. 
3. The concurrent study by Victoria Baxter – mice were intranasally inoculated and 
sacrificed for FFPE of whole brains and spinal cords. Only day 3 and 7 were 
included in this study.   
Slide rehydration. All slides were rehydrated before any staining. First, slides 
were baked at 58
O
C to melt paraffin and then immersed in xylene substitute 2 times, 6 
minutes each. The slides were serially submerged 2 times, 1 minute each, in an ethanol 
gradient from 100%, 95%, and then 70%. For RNA FISH, the slides were left in 70% 
ethanol at 4
O
C for at least 1 hour. If no RNA FISH was involved, the slides were put 
under running dH2O for 5 minutes. DEPC-treated H2O (Quality Biological) was used for 
all steps of the RNA FISH protocol. 
Antigen retrieval. For FISH and TUNEL, antigen retrieval was done by 
proteinase K digestion. The rehydrated slides (in either 70% ethanol or dH2O) were 
immersed in PBS for 10 minutes. Then 50-150 μl of prewarmed 10 μg/ml proteinase K in 
PBS was put on each slide. A hydrophobic pen (PAP Pen) or coverslip could be used to 
lower the amount of the reagents needed. The slides were incubated in a slide box with 
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wet tissue paper on the bottom (humid chamber). They were then washed twice, 3 
minutes each, in either PBS or RNA FISH washing buffer. 
 For IF and IHC, heat retrieval was applied. The rehydrated slides in dH2O were 
boiled in 0.01 M sodium citrate pH 6.0 (2.94 g sodium citrate (Sigma) in dH2O 1 liter, 
adjusted pH by HCl) with a 1000-watt microwave, 60% power, for 9 minutes. After 
letting the slides in the buffer cool at room temperature for 20 minutes with intermittent 
shaking, they were immersed in PBS for 10 minutes. 
 For protein detection, heat retrieval was the best, followed by proteinase K and no 
retrieval. In contrast, for RNA detection, proteinase K was the best, followed by no 
retrieval, and heat retrieval was the worst. 
Endogenous peroxidase quenching. This step was done only when peroxidase 
was used in the detection process. After antigen retrieval, the slides were immersed in 3% 
H2O2 in methanol (7 ml 30% H2O2 and 63 ml methanol) for 10 minutes. The slides were 
washed 3 times, 3 minutes each, in PBS. Because this could decrease the amount of RNA 
detected, it was omitted in any experiments that involved RNA FISH. Without this step, 
the background was still acceptable. 
Fluorescence in situ hybridization (FISH) of Sindbis viral RNA. The stocks of 
25 μM Custom Stellaris RNA FISH probes (LGC Biosearch Technologies) in TE buffer 
(10 mM Tris-HCl, 1 mM EDTA, pH 8.0) were diluted in hybridization buffer (10% 
dextran and 10% deionized formamide in 2x saline-sodium citrate (SSC)). The dilutions 
were 1:100 for the probe against Sindbis viral genomic (nsP2, fluorescein) and 1:1000 for 
subgenomic (E1 or E2, Quasar570) RNAs. 
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After proteinase K digestion, the slides were washed twice, 3 minutes each, in 
washing buffer (10% deionized formamide in 2xSSC). Then 100 μl of hybridization 
buffer with RNA FISH probe(s) was applied on to each slide and covered by a coverslip. 
The slides were incubated at 37
O
C overnight in a humid chamber. 
Next day, each slide was washed at 37
O
C twice, 30 minutes each, with 1 ml 
washing buffer. DAPI (Sigma) was sometime added to the 2
nd
 wash at 25 ng/ml. 
Alternatively, the same probes could be biotinylated with 5’end biotinylation kit 
(Vector) and used the same protocol. However, after the 2
nd
 wash, the ABC Elite kit was 
applied as in the IHC protocol, followed by color development with DAB or TSA 
amplification as in the protocols below. 
Immunofluorescence (IF) and immunohistochemistry (IHC). The non-specific 
binding of antibodies was blocked with 0.04% tritonX in PBS with 10% normal goat 
serum (NGS) at room temperature for 20 minutes. After brief rinsing of slides with PBS, 
150 μl of 0.04% tritonX in PBS with 5% NGS containing diluted primary antibody(ies) 
was applied to each slide and incubated at 4
O
C overnight in a humid chamber. A 
coverslip and/or a hydrophobic pen was applied to prevent the solution from running off 
the slide. The primary antibodies against viral components were mouse antibodies – 
dsRNA [J2] (Scicons), E1 [161], E2 [127]; rabbit antibodies – nsP3 [0857], capsid, 6K, 
poly-antigens (polyNSV). The cell marker antibodies were against mature neurons 
(NeuN – mouse [A60], Millipore MAB377 and rabbit [EPR12763], Abcam ab177487), 
immature neurons (DCX – mouse [E-6], Santa Cruz Biotechnology sc-271390), neural 
stem cells (Nestin – rat [7A3], Abcam ab81462), oligodendrocytes (Olig2 – rabbit  
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[EPR2673], Abcam ab109186 and PLP – rat [AA3], a gift from Ansi Chang and Bruce 
Trapp, Department of Neurosciences, Cleveland Clinic), astrocytes (GFAP – rabbit 
polyclonal, Abcam ab7260), microglia/macrophages (Iba1 – rabbit, Wako 019-19741), 
B-cell (B220 – rat [RA3-6B2], Abcam ab64100), and T-cells (CD3 epsilon – rabbit 
polyclonal, Abcam ab49943). All primary antibodies were diluted to 2.5 – 5 μg/ml for 
staining. 
Next day, the slides were washed 3 times, 3 minutes each, with PBS. The species-
matched secondary antibodies were diluted at 1:200 in 0.04% tritonX in PBS with 5% 
NGS. The secondary antibodies for IF were against mouse, rat, or rabbit IgG (H+L), 
conjugated with AF488 (Invitrogen), AF594 (Invitrogen), or CF633 (Biotium). Anti-
mouse IgG-Dylight594 (gamma-chain specific, Abcam ab98738) and anti-mouse IgM-
AF488 (mu-chain specific, Invitrogen A21042) were also used to detect classes of 
endogenous antibodies. DAPI (Sigma) was added at 25 ng/ml if desired. For IHC, 
secondary antibodies were biotinylated anti-mouse, rat, or rabbit (H+L, Vector) at 1:300 
dilution. 150 μl of the diluted secondary antibodies was applied to the slides, incubated at 
room temperature for 30 minutes. Then the slides were washed 3 times, 3 minutes each 
with PBS. For IF, the slides were ready for mounting.  
For IHC, 150 μl of avidin-HRP (horseradish peroxidase) complex mixture (ABC 
Elite Kit, Vector; 2 drops solution A and 2 drops solution B in 5 ml PBS) was applied to 
each slide at room temperature for 40 minutes. The slides were then washed 3 times, 3 
minutes each in PBS.  
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For color development, the slides were incubated with150 μl of 3,3’-
diaminobenzidine (DAB) substrate (Vector; 2 drops buffer, 4 drops DAB, and 2 drops 
H2O2 in 5 ml dH2O) at room temperature for 8 minutes. The slides were then immersed in 
running dH2O for 5 minutes. 
Alternatively, TSA (protocol below) was applied instead of the DAB substrate. 
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). 
Staining was carried out using the TACS 2 TdT Core Kit (Trevigen 4810-30-CK), 
according to the manufacturer’s protocol. After proteinase K digestion and quenching 
steps, the slides were immersed in 1x TdT labeling buffer for 5 minutes. Then each slide 
was incubated with 50 μl of labeling reaction buffer (1 μl dNTP mix, 1 μl TdT enzyme, 1 
μl Mn
2+
, and 50 μl 1x TdT labeling buffer), covered by a coverslip, at 37
O
C for 60 
minutes in a humid chamber. The slides were then immersed in 1x TdT stop buffer for 5 
minutes, and washed twice with PBS, 2 minutes each.  
Each slide was incubated with 50 μl of Strep-HRP in PBS (1 μl Strep-HRP and 50 
μl PBS) for 10 minutes at 37
O
C in a humidity chamber. The slides were washed twice in 
PBS, 2 minutes each. 
 For color development with DAB, the above protocol for IHC was followed. For 
fluorescence, streptavidin-AF488 gave a poor signal. Thus, tyramide signal amplification 
was needed. 
Tyramide signal amplification (TSA). According to the TSA Kit (Invitrogen) 
protocol, this method can be applied to any system that uses HRP for detection. HRP 
activates multiple tyramide-dyes. These many tyramide radicals then covalently bind to 
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nearby nucleophilic residues, resulting in the amplification of the signal. In this study, 
tyramide-AF488 was used according to the manufacturer’s protocol. It successfully 
enhanced the signal in immunostaining, FISH, and TUNEL.  
 After rinsing off the HRP (the mixture of ABC Elite kit or Strep-HRP) with PBS, 
each slide was incubated with 100 μl of amplification buffer with 0.0015% H2O2 and 
tyramide (1:100 dilution from DMSO stock) at room temperature for 5 minutes. The 
slides were then washed 3 times, 3 minutes each, with PBS. 
Combined RNA FISH and IF. The heat retrieval, quenching, and blocking steps 
were avoided. Primary antibody was added to the hybridization buffer and incubated 
together with the Stellaris probe(s) overnight as in FISH protocol. The secondary 
antibody step was added between the first and second washes: each slide was incubated 
with 100 μl of 1:200 secondary antibody(ies) in hybridization buffer at 37
O
C for 30 
minutes. 
 Combined TUNEL-TSA, RNA FISH, and IF. TUNEL-TSA did not affect the 
result of IF, and vice versa, when performed sequentially. However, RNA FISH first 
completely abolished the later TUNEL-TSA signal. On the other hand, TUNEL-TSA first 
partially decreased the later RNA FISH signal, but was acceptable.  
 After proteinase K digestion, without quenching or blocking, TUNEL-TSA was 
applied to each slide first, followed by combined RNA FISH/IF.  
Imaging 
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 DAB staining (brown) was captured in bright field with Nikon TE800. The 
fluorescence imaging was captured with various epifluorescence microscopes, which 
were Nikon TE800, Nikon TE2000, Nikon 90i, and Zeiss Axio Imager M2. The filter sets 
were DAPI (DAPI), FITC (AF488, fluorescein), Texas Red (AF594, Quasar570), and 
Cy5 (CF633). The imaging software was Spot Advance (Nikon TE800 and Nikon 
TE2000) and Volocity (Nikon 90i and Zeiss Axio Imager M2). Zeiss Axio Observer Z1 
with LSM780FCS confocal microscope and Zen software was also used. The lasers used 
were 405 nm (DAPI), 488 nm (AF488, fluorescein), 561 nm (AF594, Quasar570), and 
633 nm (CF633). 
Neonatal mouse brain inoculation 
For testing whether there were still a small number of infectious virions 
undetectable by plaque assay in the adult mouse brains at 14 days after infection with 
SINV TE, 26 CD1 and 36 C57BL/6 neonatal (day 0) mice were intracerebrally injected 
with 10 μl of pooled 10% brain homogenates (day 14 post TE). The pup whole brains 
were collected at either day 3 or day 7 after inoculation. The whole brains were 
homogenized in Lysing Matrix D (MP Biomedicals), filled with 1 ml ice-cold PBS, by 
FastPrep-24 (MP Biomedicals; speed 4 m/s, 40 seconds). The homogenates were tested 
for infectious virions by plaque assay (see Chapter 4). 
Brain slice culture (Figure 2.1) 
 Mouse organotypic brain slice cultures were done to see whether persistent 
Sindbis virus could reactivate after the supply of immune cells and antibody from 
circulation had been eliminated. Three 5-week-old C57BL/6 mice, infected 
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intracerebrally with SINV TE as described above, were sacrificed on day 21 after 
infection (long after infectious virion had been cleared).  
 The process was adapted from organotypic hippocampal slice culture by 
Hyunjeong Kim, et al (67). After isoflurane euthanasia, intracardiac infusion of 15 ml 
ice-cold dissection medium (Hybernate A, 2% B27, 2mM glutamine, 1% PenStrep, all 
from Gibco), the brain was removed and immersed in a petri dish filled with ice-cold 
dissection medium. To prevent sticking to the razor blade, the brain was embedded in ice-
cold precast 1.2% bacto agar on autoclaved Whatman filter paper. The agar-embedded 
brain was sliced, 300-μm thickness, with a McIlwain tissue chopper. Each slice was 
placed on a Transwell insert inside a 6-well plate filled with prewarmed slice culture 
medium (Neurobasal A, 2% B27, 2 mM glutamine, 1% PenStrep, all from Gibco). Two 
to three slices were put on each insert and each mouse had 2 inserts. The slices were 
cultured at 37
O
C 5% CO2. The supernatant fluids were collected and completely replaced 
with fresh culture medium everyday. The collected fluids were tested for SINV-specific 
IgG by ELISA. To assay for infectious virions, 50 μl of the supernatant fluid was added 
to BHK cells in a 96-well plate. The cells in each well were observed for cytopathic 
effect with an inverted microscope for 48 hours after infection. 
Sindbis-specific enzyme-linked immunosorbent assay (ELISA) 
 Because mouse serum IgM strongly reacted with non-infected BHK lysate, using 
infected cell lysates for coating was not appropriate. TE-infected culture medium diluted 
in coating buffer gave much less background, but PEG-concentrated TE (see the 
preparation above) was better. Furthermore, PEG-treated TE coating was much more 
 34 
efficient (200-1000 ELISA plates/T150 flask of BHK culture) than the traditional TE-
infected cell lysate (1-5 ELISA plates/T150 flask). 
 Each well of the Maxisorp (Nunc) 96-well plate was coated with 10
6
 pfu PEG-
treated TE in 50 μl coating buffer (50 mM NaHCO3 pH 9.6) at 4
O
C overnight in plastic 
wrap. The plate was washed once with 200 μl/well of washing buffer (PBST-2% FBS; 
PBS, 0.05% Tween20, 2% FBS) and then blocked with 200 μl of blocking buffer (PBST-
10% FBS) at 37
O
C for 2 hours.  
 The plate was washed twice with washing buffer. The samples were diluted in 50 
μl of blocking buffer at 1:100 for serum, 1:8 for 20% brain homogenate, and 1:2 for 
supernatant from brain slice culture. The plate was incubated with diluted samples, each 
in triplicate, at room temperature for 2 hours. 
 The plate was washed 4 times with washing buffer. Each well was then incubated 
with the desired secondary antibodies (HRP-conjugated anti-mouse IgG, IgG1, IgG2a, 
IgG2b, IgG3, IgM, or IgA; SouthernBiotech) diluted 1:1000 in 50 μl blocking buffer at 
room temperature for 1 hour. 
 The plate was washed 4 times with washing buffer and then incubated with 100 
μl/well of TMB substrate (BD OptEIA TMB substrate Reagent Set, BD Biosciences) at 
room temperature up to 20 minutes. The reaction was stopped with 25 μl/well of H2SO4. 
The optical density (OD) was read at 450 nm with Multiskan MCC (Thermo Scientific). 
Long-range reverse-transcription polymerase chain reaction (RT-PCR)  
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 RT-PCR to detect Sindbis TE viral RNA was performed on 4 μg of brain RNA 
extract in 20-μl reaction, using LongRange 2Step RT-PCR Kit (Qiagen) according to the 
manufacturer’s protocol. Long-range reverse transcription was done with a thermocycler 
(42
O
C 2 hours, 85
O
C 5 minutes) using either oligo-dT or Sindbis-specific oligo-dT 
(Figure 2.15 GTAAAG-oligo-dT, included the last 6 complementary bases of SINV TE 
before poly-A). Then PCR was performed on 2 μl of the long-range cDNA in 50-μl 
reaction. The primer pairs were SV1400F-SV4100R (nsP1-nsP2), SV8996F-SV11384R 
(E2-E1), and SV8456F-SV11384R (E3-E1). The thermocycler setting was 3-minute hold 
at 95
O
C; 40 cycles of 95
O
C 30 seconds, 55
O
C 30 seconds, and 68
O
C 3 minutes; and then 
2
nd
 hold at 68
O
C for 5 minutes. The PCR products were subjected to agarose gel 
electrophoresis. Pictures of the ethidium bromide-stained gels were captured with Gel 
Doc (Bio-Rad). 
Immunoprecipitation of Sindbis virus replication complex 
 10 μg of anti-nsP3 (rabbit 0857) (68, 69) was incubated with 200 μg of protein 
(measured in brain homogenates by Pierce BCA Protein Assay Kit, Thermo Scientific) in 
600 μl of RIPA buffer at 4
O
C for 2 nights on a rocker. 20 μl of protein A plus agarose 
(Pierce) was equilibrated with RIPA buffer. After removing the buffer, the agarose was 
mixed with the anti-nsP3-brain complexes and rocked at 4
O
C overnight. The agarose 
beads were washed 6 times with RIPA buffer, and then boiled (heat block, 95
O
C) in 20 μl 
of SDS/βME lysis buffer. The whole supernatants were loaded onto a gel (see below).  
SDS-PAGE and Western blot 
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 Whole immunoprecipitate or 20 μg of protein in brain homogenate was loaded 
onto each lane of a precast gel (BioRad). Electrophoresis was run at 200 V in running 
buffer (25 mM Tris base, 0.2 M glycine, 0.1% SDS). The proteins on the gel were 
transferred to a nitrocellulose membrane at 100 V for 1 hour in transfer buffer (25 mM 
Tris base, 0.2 M glycine, 20% methanol). The membrane was blocked with 10 ml of 5% 
skim milk in TBST (20 mM Tris, 150 mM NaCl, 0.1% Tween20) at room temperature 
for 1 hour. Overnight incubation on a rocker at 4
O
C was done with either rabbit anti-
NeuN (1:5000, clone EPR12763, Abcam) or mouse anti-NeuN (1:500, clone A60, 
Millipore) in TBST with 5% bovine serum albumin (BSA, Sigma). After washing with 
TBST, either anti-rabbit-IgG-HRP or anti-mouse-IgG-HRP in TBST with 1% skim milk 
at room temperature for 1 hour. Substrate was added, and the chemiluminescence was 
detected by film. 
Results:  
 Two patterns of viral distribution. There were two patterns of viral distribution 
in CNS, white and gray matter tropisms (Figure 2.2). After intranasal inoculation, it was 
always a gray matter pattern, while intracerebral injection could result in both white and 
gray matter infection (Figure 2.3). 
 In gray matter tropism, infection began with a few infected cells scattered over the 
cerebral cortex, hippocampus, and basal ganglia on day 1. Later, the infection spread and 
formed multiple clusters of infected cells (Figure 2.2, 2.3).  
 In white matter tropism, infection began with diffuse involvement of white matter 
tracts, especially the corpus callosum and periventricular white matter as early as day 1. 
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Later, the infection spread to the adjacent pyramidal neurons in the CA1 layer of the 
hippocampus (Figure 2.2, 2.3). 
 The numbers of infected cells reached a peak on day 3 for both patterns, and then 
gradually declined. At late times, the patterns remained the same as at the early times. In 
white matter tropism, infection in the hippocampus was cleared first. In gray matter 
tropism, clearance began at the center of infected cluster, which represented the cells of 
early infection (Figure 2.3). Both FISH and IF detected infected cells up to 4 weeks after 
infection. 
 During late time points (day 7 and beyond) in both tropisms, the amount of viral 
RNA and proteins declined at the original sites of infection (Figure 2.4). SINV E1 
protein appeared in autofluorescent brown-pigment macrophages (Iba+) that infiltrated 
the pia mater and blood vessels close to the infected sites. These macrophages also 
directly infiltrated infected areas, beginning on day 7-10, and were most abundant around 
1 month after infection (Figure 2.4-2.6). 
 Two types of infected cells. Cell types that were infected mainly depended on the 
distribution patterns (Figure 2.7). For white matter tropism, the infected cells were 
mostly oligodendrocytes (Olig2+/-, PLP+). The infection decreased Olig2 expression 
(Figure 2.8), so more than one marker was needed to identify the cells. The spread of 
infection to hippocampus involved pyramidal neurons (typical cell shape in CA1 layer), 
which were positive for NeuN in the cytoplasm. 
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 For gray matter tropism, the infected cells were neurons (NeuN+). However, the 
usual nuclear NeuN was relocalized to the cytoplasm in the infected cells. For neurons 
that contained no virus, NeuN was still in their nuclei (Figure 2.7, 2.9).  
 Suppression of NeuN. SDS-PAGE and Western blot of pooled infected-brain 
homogenates showed depletion of NeuN both 45 and 50 kD isoforms from day 7 until 
day 60, before recovering on day 90. NeuN could also be co-immunoprecipitated by anti-
nsP3, the antibody for precipitation of SINV replication complex (Figure 2.10). 
 Persistent viral components. At peak of infection, day 3, all viral components 
could be found in abundance (Figure 2.11). However, from day 7 onward, the most 
prominent component was viral capsid, followed by viral subgenomic RNA (Figure 
2.12). Genomic RNA was no longer detectable. Other components could be seen in a 
small number of cells. Unlike on day 3, the viral envelope proteins (E1 and E2) were seen 
only inside the cells, not on the plasma membrane at late time points. E1 could also be 
seen in macrophages (see above). Most viral components were seen only in the cell body 
at late time points. In contrast, viral components were found in dendrites and axons in the 
early phase. 
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Table 2.1 Viral components detected in brains 
 
 Persistent viral RNA only found in live cells. TUNEL, a test for cell death, was 
never positive in nuclei of cells that contained viral RNA, detected by FISH. Cells that 
had viral RNA always expressed some viral proteins (Figure 2.13), especially the capsid 
protein. Infected cells that contained viral proteins without RNA could be either positive 
or negative for TUNEL (Figure 2.14). 
No infectious virus detected by newborn mouse brain inoculation. CD1 
newborn mice intracerebrally injected with D14-infected brain homogenate had no 
infectious virus detected. The experiment was repeated with fresh D14-infected brain 
homogenates on C57BL/6 newborns. Again, none of them had any infectious virus in 
their brains either 3 or 7 days after infection. 
 Prolonged anti-SINV antibody production without viral reactivation ex vivo. 
ELISA could detect SINV-specific antibody in supernatant fluids from brain slice 
cultures of mice 3 weeks after infection for up to 3 weeks ex vivo (Figure 2.15). No viral 
reactivation was found from slice cultures up to 4 weeks. 
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 No complete genome detected in persistent SINV RNA. Both genomic and 
subgenomic SINV RNA could be detected by long-range RT-PCR in D3-infected brain 
RNA extract. However, in day 14 and 21 brain RNA, intact genomic RNA was not 
detectable, and multiple sizes of subgenomic RNA were found on agarose gel 
electrophoresis (Figure 2.16). 
Table 2.2 Summary of persistent virus 
 
Discussion: 
 The distributions and cell types during viral persistence are the same as in the 
early phase of infection and depend on the inoculation technique. Interestingly, Sindbis 
virus can infect neurons in gray matter, while sparing oligodendrocytes in white matter, 
and vice versa.  
 All intracerebrally inoculated brain tissues from previous study #1 (Talibah’s) 
(50) and my early samples resulted in 100% white matter patterns. However, later on, the 
patterns shifted to approximate 1:1 ratio of white versus gray. This coincided with the 
change from 100- to 30-unit insulin syringes for intracerebral injection, since the tiny 
scale of the former was much harder to precisely deliver 20 μl of inoculum. Most of the 
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time, the volume was doubled when using 100-unit syringes. This suggests that the 
higher volume contributes to the higher chance of white matter tropism. The explanation 
is probably that the mouse brain left hemisphere, 90 μl (70), cannot contain the inoculum, 
which leaks into the cerebrospinal fluid (CSF) in the ventricular system and causes rapid 
widespread infection in periventricular white matter. 
 In the gray matter distribution, the infection begins with a few discrete infected 
cells, far apart from each other, in cerebral cortex of the right hemisphere. This suggests 
long distance transmission of virus from the inoculation site in the left hemisphere. The 
virus probably spread through the synapse of the long axon across the corpus callosum. 
After that, infected cells spread the virus to adjacent neurons and form an expanding 
cluster of infection. Sometimes, axon connections between foci can be observed. 
 Types of susceptible cells that Sindbis virus first encounters likely determine the 
tropisms. In intranasal inoculation, these very first susceptible cells will be in the 
olfactory neuroepithelium. If the intracerebral inoculum does not leak into the ventricles, 
the virus will infect the neurons that surround the injection site. However, if the inoculum 
does leak, the virus will infect oligodendrocytes in periventricular white matter instead. 
We can ensure the white matter tropism by increasing the volume of inoculation. This 
may be an alternative model for multiple sclerosis, after experimental autoimmune 
encephalomyelitis (EAE) and Theiler's murine encephalitis virus-Induced demyelinating 
disease (TMEV-IDD) (71). 
The virus continues to target the same type of cells that it first infects. This ‘viral 
imprint’ might be due to an adaptation of the virus to particular host cells. In clinical 
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disease, some viruses also variously distribute in the nervous system, involving different 
cell types. For instance, cytomegalovirus (CMV) can cause polyradiculitis, focal brain 
lesions, encephalitis, or ventriculitis (72). 
Some of autofluorescent-pigmented macrophages that appear at late time points 
contained SINV E1 protein. The viral protein was not freely distributed in cytoplasm. 
Thus, these macrophages most likely phagocytosed infected cells. So far, only E1 has 
been found in macrophages. It might be more resistant to proteases than other viral 
proteins. Finding these macrophages along the pia mater or blood vessels close to the 
infection sites suggests that resident cells of brain cannot clear all the viral proteins and 
need macrophages from the periphery for removal. 
Sindbis virus infection also remarkably alters the cell marker expressions. It 
abolishes Olig2 in oligodendrocytes, and relocalizes NeuN from the nucleus to the 
cytoplasm in neurons. Other viruses and conditions can cause these phenomena too. EAE 
and TMEV-IDD deplete Olig2, a transcription factor involved in oligodendrocyte 
development, and inhibit remyelination (73, 74). 
NeuN, also known as rbFOX3, is a splicing factor that controls alternative 
splicing of another splicing factor, rbFOX2 (75). The RNA binding site of NeuN is 
UGCAUG, which is found in TE both in the plus strand (7 sites - nsP1, nsP2, nsP3, 2 in 
nsP4, E2, E1) and minus strand (2 sites - nsP1, nsP4). Its use in viral replication might 
partially explain the neurotropism of SINV. There are 4 major isoforms, 2 in 50 kD and 
another 2 in 45 kD ranges. All retain their splicing activity. The cytoplasmic predominant 
isoform is one of the 45 kD isoforms (75). However, co-immunoprecipitation with anti-
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nsP3 shows the 50 kD isoform(s) is the one that associates with viral replication complex. 
Thus, the SINV-induced cytoplasmic NeuN is likely due to the retention of nuclear 
isoform(s) in the cytoplasm rather than the accumulation of the cytoplasmic isoform.  
Some exceptions for nuclear-localized NeuN include Dogiel type II neurons in 
guinea pig intestines, which express cytoplasmic NeuN (76). Some pathologic conditions 
can also alter the NeuN expression pattern. Cerebral ischemia can deplete NeuN 
immunoreactivity in intact neurons (77, 78). HIV encephalopathy can cause NeuN 
depletion and cytoplasmic relocalization in uninfected neurons affected by the secretion 
of Tat protein from HIV-infected microglia (79, 80). 
The change of RNA binding protein localization from nucleus to cytoplasm by 
Sindbis virus has also been observed for HuR, an mRNA stabilizing protein (81). This 
phenomenon in mammalian cells is quite specific to alphaviruses, and occurs in Sindbis, 
Ross River, Western equine encephalitis, and Chikungunya, but not dengue or measles 
viruses (82). The high affinity binding sites between HuR and alphaviral RNAs are at a 
U-rich element (URE, just upstream of CSE) in Sindbis virus and 3’ terminal conserved 
sequence element (CSE) in all alphaviruses. The cytoplasmic localization of HuR 
requires neither URE nor the presence of viral RNA. Instead, it requires viral replication 
and/or expression. Caspase-induced cleavage of HuR is another mechanism for 
cytoplasmic HuR localization found in stress, but not in SINV infection. SINV infection 
can also induce dephosphorylation of HuR localization, a mechanism not yet found in 
other conditions. This is likely the major mechanism for cytoplasmic localization of HuR, 
because Cdk1-induced phosphorylation of HuR is responsible for its nuclear 
accumulation (83). All major isoforms of NeuN are also phosphorylated (84). Thus, the 
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SINV-induced dephosphorylation might apply to SINV-induced cytoplasmic localization 
of NeuN too. 
 In addition to relocalization, SINV remarkably depleted all major isoforms of 
NeuN, shown in Western blot. Considering the small percentage of infected neurons, 
most uninfected neurons must be affected too, similar to HIV encephalopathy (79, 80). 
Unlike the cytoplasmic relocalization, depletion does not happen on post infection day 3, 
the peak of infectious virion and viral RNA titer, but later during clearance on day 7 to 60. 
Thus, inflammation rather than virus infection itself likely causes the depletion.  
 Contrary to what we had expected, detectable viral proteins (IF) persist longer 
than viral RNA (FISH), especially viral capsid in dying cells and E1 protein in 
macrophage phagosomes. FISH and IF are at least 100 times less sensitive than RT-qPCR. 





GAPDH RNA (see chapter 3), while RT-qPCR can easily detect 100 
viral RNA copies for many months. 
 The persistent viral RNA most likely retains its function of protein translation, 
because it is found exclusively in live cells that express one (capsid) or more viral 
proteins. However, there are no data on the half-life of these proteins in infected cells. 
Thus, viral proteins may just outlive their encoding mRNA.  
 The persistent viral RNA is unlikely to be replication-competent, because 
genomic RNA is not detectable by FISH or long-range RT-PCR. Nevertheless, we can 
detect dsRNA up to 1 month after infection. Anti-dsRNA is a mouse antibody, making it 
impossible to distinguish the high background in mouse brains from the small amount of 
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dsRNA at later time points. Theoretically, dsRNA in viral replication complexes is a 
duplex of full genomic plus and minus strands. Therefore, there might be some intact 
viral genome left. In fact, in a mouse model of Coxsackie B viral encephalitis, the 
genomic plus/minus ratio declines over time and approaches 1:1 at late time points, 
which suggests that persistent RNA is double-stranded in nature (65). Unfortunately, 
neither methods for FISH nor long-range RT-PCR for dsRNA has yet been established. 
 How can the virus persist in the presence of high neutralizing antibodies at late 
time points? The absence of antibody on the surface of infected cells (Figure 2.17) 
suggests that anti-SINV antibody (found abundantly in brains with ELISA) cannot bind 
to the cell membrane of infected cells. The long-range RT-PCR also shows that there are 
some large deletions of E2-E1 gene by day 14. Thus, the lack of expression of envelope 
proteins may help the virus avoid antibody-mediated clearance, but renders the virus 
unable to be reactivated. 
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Figure 2.1 Brain slice culture procedure. The precast agar was prepared beforehand by 
pouring the liquefied (by microwave) 1.2% bacto agar into the mold made of clean filter 
paper, a Transwell insert (membrane removed), and a glass tube (A). The insert and the 
glass tube were removed after solidification of the agar (B). This precast agar was kept on 
ice inside a 60-mm dish. The brain was placed inside the center pit and more liquefied 
agar was added just to cover the brain (C). After the entire agar solidified, 300-μm 
thickness of the agar-embedded brain on filter paper was sliced by a McIlwain Tissue 
Chopper (D). The excess agar was removed by scalpel and the chopped brain was 
returned to the dissection medium. Each slice was separated by a spatula and scalpel (E). 
The slice was then placed on a 37
O
C prewarmed Transwell insert with slice culture 
medium in a 6-well plate (F). 
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Figure 2.2 Mouse brains, 3 days post infection, show widespread white matter 
distribution (A) after intracerebral injection and multi-cluster gray matter distribution (B) 
after intranasal inoculation (red – SINV E1 RNA, green SVpolyAg). Higher 
magnification (C) of the white matter pattern shows the virus spreading to pyramidal 
neurons in the CA1 layer of the hippocampus (green – SVpolyAg, red – PLP). Higher 




Figure 2.3 Right hemispheres of mice, intracerebrally injected with SINV TE from 
day1-10. These images demonstrate the progression of viral spreading and clearance in 
mouse brain (white – SvpolyAg, blue – Dapi). Though inoculated in the same way, the 
distribution patterns are opposite between the white matter pattern (upper row) and gray 
matter pattern (lower row). 
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Figure 2.4 Image shows distribution of SINV protein (white) in a mouse brain, 3 weeks 
after infection. While the host clears most of the viral protein in the original infected 
areas (white arrows), the viral protein now can be seen in the wall of a blood vessel 
(yellow arrow) and along the thickened pia mater (white arrow). 
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Figure 2.5 Autofluorescent pigmented macrophages. The image of a mouse brain, 26 
days after infection, show autofluorescene in both red (A) and green (B) channels in the 
absence of fluorescent dye, except Dapi. The merged image (C) shows the 
autofluorescence in orange color, which colocalizes with the brown pigment, observed in 
phase-contrast (D). These cells are macrophages (see the next figure). 
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Figure 2.6 The image shows infiltration of the falx cerebri and corpus callosum by 
autofluorescent macrophages (orange) in the mouse brain, 26 days after TE infection. 
Autofluorescent macrophages (orange) infiltrate the pia mater (B) together with antibody-
producing cells (green). One macrophage also contains SINV proteins (red). Zoom-in 
image C shows SINV proteins (green) in a cell containing autofluorescent (orange) 
pigment. The cell (D) with autofluorescence (yellow arrow) is positive for a macrophage 
surface marker, Iba1 (red), and the viral protein found inside is E1 (green arrow). 
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Figure 2.7 The images show cell types in brains 3 days after infection with SINV TE. In 
white matter tropism, infected cells are mostly oligodendrocytes (A – Olig2 (red) and SV 
E1E2 (green); B – PLP (red) and SVpolyAg (green)). In gray matter tropism (C), infected 




Figure 2.8 In the same mouse brain, 3 days post SINV TE infection, the infected area (A) 
loses the Olig2 signal (yellow) along the white matter tract, while the non-infected area 
(B) retains the signal. (red – SINV RNA E1E2, blue – Dapi) 
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Figure 2.9 In the mouse brain, 3 days post SINV infection, the infected cells (green – 
E1E2) lose NeuN (red, different monoclonal antibody from Figure 2.7) signal in their 
nuclei, but have NeuN in the cytoplasm. 
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Figure 2.10 Western blot of TE-infected brain homogenates (pooled from 3 mice/time 
point) during day 0-60 shows the decrease of NeuN from day 7-60 post SINV TE 
infection (A). Immunoprecipitation with anti-nsP3 (B) co-precipitates NeuN on day 3 
after infection (B). 
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Figure 2.11 All viral components are found in abundance in mouse brains, 3 days post 
SINV TE infection. 
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 Figure 2.12 On day 7 after SINV TE infection, the main viral components found are 
subgenomic RNA (A – red) and capsid (B – green), while nsP3 (C – red), envelope (C – 
green), and dsRNA (D – green) are found infrequently. 
 58 
 
Figure 2.13 On day 7 after SINV TE infection, infected cells along the corpus callosum 
still have both SINV subgenomic RNA (red) and proteins (green), while only proteins 
(green) persist in lateral septal nucleus. 
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Figure 2.14 The image shows combined TUNEL-TSA (green), RNA FISH E1E2 (red), 
and IF SVpolyAg (white) of the infected area in the mouse brain, 7 days post SINV TE 
infection. The merged photo shows that TUNEL (green) is always negative in the 
infected cells that still have viral RNA (red).  
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Figure 2.15 The image of 6 by 6 tile scan (A) shows that this brain slice, infected with 
SINV TOTO E2-mCherry at 1 week ex vivo in Transwell insert, still survives and has 
some infected cells (red) 3 days after ex vivo infection. The graph (B) demonstrates the 
SINV-specific IgG-ELISA from supernatants (1:2 dilution) of mouse brain slice cultures, 
taken on day 21 post infection with SINV TE. The OD value in each day is the average of 
supernatants collected from 6 wells (3 brain slices/well, 2 wells/mouse, 3 mice in total).
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Figure 2.16 Images of agarose gel electrophoresis of long-range RT-PCR products from 
mouse brain RNA extracts, using GTAAAG-oligo-dT as a primer. Only day 3 is positive 
for PCR that covers nsP1 and nsP2, which represent genomic RNA (F after the date 
means RNA is extracted from fresh brains without any freeze-thaw). On the other hand, 
the subgenomic area (E2 and E1) is still detectable on day 14, but mostly smaller sizes, 
suggesting large deletions. 
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Figure 2.17 The images (A – objective lens 20x, B – 100x, orthogonal view) of the 
mouse brain, 7 days after SINV TE infection, show that no endogenous immunoglobulin 
(green) binds to the surface of infected cells (red – SINV subgenomic RNA). 
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Chapter 3 
Antibody-mediated clearance of Sindbis virus from mouse CNS 
Introduction: 
 The key components that clear Sindbis virus from the CNS are antibody and 
interferon-gamma (IFN-γ) (21). In this chapter, we will focus on antibody-mediated 
clearance. 
In vitro  
 Without leukocytes or complement, mouse monoclonal anti-SINV E2 IgG of any 
subclass can inhibit Sindbis viral replication in infected primary cultures of neurons from 
rat dorsal root ganglia (85, 86). The Fc portion of antibody is not necessary, because the 
bivalent F(ab’)2 retains its antiviral activity. However, the monovalent F(ab) loses this 
ability, but both bivalency and antiviral properties can be simultaneously restored by 
cross-linking with a secondary antibody. This underlines the importance of cross-linking 
of membrane viral E2 glycoprotein on viral clearance (86). 
 Rat prostatic adenocarcinoma (AT3) cells that overexpresses bcl-2, a cellular 
inhibitor of apoptosis, can survive Sindbis viral infection long enough to study the viral 
clearance. In this cell line, infected with Sindbis virus, the monoclonal anti-E2 antibody 
can delay nonstructural protein synthesis and inhibit viral budding. Viral RNA replication 
increases during very first hours after treatment, but decreases afterward. Antibody 
treatment also restores host cell protein synthesis, membrane potential, and antiviral 
activity of IFN-α in late infection (87, 88). 
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In vivo 
 Various monoclonal antibodies have been tested for prevention of disease induced 
by lethal neuroadapted Sindbis virus (NSV) in a mouse encephalitis model. While anti-
capsid antibodies have no effect, many anti-E1 and anti-E2 antibodies show protection 
(given 24 hours before infection) and/or clearance (given 24 hours after infection) (89). 
Interestingly, neutralization, cell-lysis with complements, and IFN-α/β function (23) are 
not required for effectiveness. Furthermore, some antibodies that offer protection fail to 
aid in recovery or clearance of established viral infection (89), suggesting that different 
mechanisms are involved in these processes.  
In severe combined immunodeficiency (SCID) mice, adoptive transfer of anti-
SINV E2 antibody can eliminate both infectious virions and viral RNA from persistently 
infected brains, while sensitized T-cells fail to do so (85). μMT mice lack all classes of 
antibody, because they do not have mature B-cells due to a defect in the μ-heavy chain. 
These mice cannot clear Sindbis virus from the brain, but they successfully clear, though 
delayed, virus from the spinal cord (43) (Figure 3.1). 
 Though IgG is very effective in the adoptive transfer model (85), only SINV-
specific IgM-secreting cells infiltrate mouse brains during the clearance of infectious 
virions (1
st
 week of infection) (51). IgG is produced a few days later and slowly increases 
during the clearance of viral RNA (2-8 weeks after infection, Figure 3.2). Furthermore, 
athymic nu/nu mice, which produce mainly IgM with little IgG, can clear the infectious 
virions normally (90). We hypothesize that, in vivo, IgM may be sufficient for virion 
clearance, while IgG may be necessary for viral RNA clearance. 
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 To test our hypotheses, we have compared wild-type C57BL/6 mice (WT) to 
three types of antibody-deficient mice; activation-induced cytidine deaminase deficient 
(AID-/-), secretory IgM deficient (sIgM-/-, also known as mu s-/-), and double knockout 
(DKO; AID-/- sIgM-/-). AID is a key enzyme for class-switch recombination and somatic 
hypermutation. Thus AID-/- mice can produce and secrete only germline IgM (no IgG, 
IgA, or IgE) (91). In contrast, sIgM-/- mice lack alternative splicing for secretory IgM, 
but are still able to produce membranous IgM and switch classes. As a result, sIgM-/- 
mice can secrete IgG, IgA, and IgE, but not IgM (92). DKO mice cannot secrete any 
antibodies. Though lacking plasma cells, DKO mice have mature B-cells, which can 
differentiate into plasmablasts (93). 
Materials and Methods: 
Mouse strains 
All mice were on C57BL/6 background. WT mice were from Jackson Laboratory 
(#000664). AID+/- and sIgM+/- mice were gifts from Matthew Scharff (Albert 
Einstein College of Medicine) and Nicole Baumgarth (University of California, Davis), 
respectively. The heterozygous mice were mated to produce homozygous AID-/- or 
sIgM-/- mice. Male AID-/- mice were then mated with female sIgM-/- mice to 
produce double heterozygous mice (AID+/- sIgM+/-), which were subsequently 
mated with their siblings to produce DKO mice (AID-/- sIgM-/-).  
Mouse phenotypes were confirmed by ELISA for serum total IgM, IgG, and 
IgA. Mouse blood was collected by either facial vein puncture or tail snip under 
isoflurane anesthesia. Because the AID+/- mothers could vertically transfer IgG to 
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their pups, serum total IgA ELISA needs to be used instead of IgG for typing before 8 
weeks, after which the transferred IgG completely disappeared. The homozygous 
mice were maintained locally, ready for simultaneous mating in each experiment.  
 Serum total Ig-ELISA 
Each well of the Maxisorp (Nunc) 96-well plate was coated with 1:400 dilution of 
serum in 50 μl coating buffer at 4
O
C (50 mM NaHCO3 pH 9.6) overnight in plastic wrap. 
The plate was washed once with 200 μl/well of washing buffer (PBST-2% FBS; PBS, 
0.05% Tween20, 2% FBS) and then blocked with 200 μl of blocking buffer (PBST-10% 
FBS) at 37
O
C for 2 hours.  
 The plate was washed twice with washing buffer. Each well was then incubated 
with HRP-conjugated anti-mouse IgM, IgG, or IgA: Southern Biotech) diluted at 1:1000 
in 50 μl blocking buffer at room temperature for 1 hour. 
 The plate was washed 4 times with washing buffer and then incubated with 100 
μl/well of TMB substrate at room temperature up to 20 minutes. The reaction was 
stopped by 25 μl/well of H2SO4. The optical density (OD) was read at 450 nm by 
Multiskan MCC (Thermo Scientific). The level of serum IgM, IgG, and IgA in each 
mouse group is shown in Figure 3.3. 
 SINV-specific Ig-ELISA is described in Chapter 2: Materials and Methods. 
Mouse infection 
Each mouse, 4-6 weeks old, was injected with 20 μl of 1000 pfu SINV TE into 
the left cerebral hemisphere. There were 4 groups of mice; WT, AID-/-, sIgM-/-, and 
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DKO. Groups of mice were observed for clinical outcomes (see below) or three 
mice/group/time point/experiment were sacrificed on day 0 (no infection), 3, 5, 7, 10, 14, 
21, 30, 45, 60, and 90. Two independent experiments were conducted. Both sexes of mice 
were used and distributed equally among four groups. 
Morbidity-mortality assay 
 Each mouse was weighed and recorded for clinical score everyday from day 0 
(just before intracerebral injection) to day 21. There were 20-30 mice per group. The 
clinical scores are; 0 – normal; 1 – slightly hunched, abnormal gait and tail position; 2 – 
very hunched, walking on hind limbs; 3 – sitting on hind limbs, discharge from eyes, 
ruffled fur on nose; 4 – death. For scoring, the investigators were blinded as to what 
group each mouse was in. 
Collection and handling of specimens 
After being euthanized with isoflurane, heart blood was drawn and spun at 6000 
rpm 4
O
C for 20 min. The serum/plasma portion was kept at -20
O
C for ELISA (Chapter 2: 
Materials and Methods). Intracardiac perfusion with ice-cold PBS was performed. The 
brain left hemisphere and spinal cord were immediately frozen in liquid nitrogen and 
stored in the Lysing Matrix D tube (MP Biomedicals) at -80
O
C, waiting for 
homogenization. 
After adding 1ml of ice-cold PBS into the Lysing Matrix D (MP Biomedicals) 
tube, the specimen was homogenized with FastPrep-24 (MP Biomedicals) at 6 m/sec 
speed for 40 seconds to make either a 20% brain homogenate or a 10% spinal cord 
homogenate. The homogenates were centrifuged at 13200 rpm at 4
O
C for 15 minutes. 800 
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μl of supernatant fluid was collected and stored at -80
O
C for plaque assay (Chapter 4: 
Materials and Methods) and ELISA (Chapter 2: Materials and Methods). 1 ml of Qiazol 
was added to the sediment and re-homogenized with FastPrep-24 (MP Biomedicals) at 6 
m/sec speed for 40 seconds. Then the RNeasy Lipid Mini Kit (Qiagen) was used to 
extract the RNA according to the manufacturer’s protocol. The RNA was quantified by 
Nanodrop and stored at -80
O
C for RT-qPCR. 
Reverse-transcription quantitative real-time polymerase chain reaction (RT-qPCR) 
 2 μg of each RNA extract was reverse transcribed by the Applied Biosystems 
2720 thermocycler (25
O
C 10 minutes, 37
O
C 120 minutes, and 85
O
C 5 seconds) with High 
Capacity cDNA Reverse Transcription Kit (Themo Scientific) in a 20-μl reaction, using 
random primers, according to the manufacturer’s protocol. qPCR was performed using 
the Applied Biosystems 7500 Real Time PCR System (50
O
C 2 minutes, 95
O
C 10 
minutes, and 40 cycles of 95
O
C 15 seconds – 60
O
C 1 minute) on 2.5-μl cDNA for SINV 
E2 (Primers – SV8732F [5’-TGG GAC GAA GCG GAC GAT AA-3’, IDT 43567022] 
and SV8805R [5’-CTG CTC CGC TTT GGT CGT AT-3’, IDT 43567023]; TAMRA 
probe SVE2-8760, Applied Biosystems 5283081), GAPDH (TagMan Rodent GAPDH 
Control Reagent, VIC probe, Life Technologies 4308313), IFN-γ (exon location 1-2, 
TAMRA probe, IDT 141107662), and AID (TagMan Gene Expression Assays 
Mm01184115_m1 Aicda, Applied Biosystems) with TagMan Universal Master Mix 
(Thermo Scientific) in a 25-μl reaction, according to the manufacturer’s protocol. 
Standards for SINV E2 (TEds plasmid) and GAPDH (TaqMan Rodent GAPDH Control 
Reagent) were serially diluted 10-fold from 3 X 10
7
 to 3 copies. SINV E2 RNA copy 
number was calculated as absolute number per 10
6
 GAPDH RNA copies. IFN-γ and AID 
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expression were calculated as fold-increase (2
-ddCT
) using the day 0 samples and GAPDH 
as controls. 
Staining and cell counting of the formalin-fixed paraffin-embedded (FFPE) brains 
The brain right hemisphere was sliced into 5 sections, 2 mm thickness each, and 
fixed in 4% paraformaldehyde in PBS pH 7.2 at 4
O
C overnight. The fixed brains were 
then processed as in the previous chapter (Chapter 2: Materials and Methods). IF was 
used to stain the FFPE brain slices for endogenous IgG, IgM, and SINV (anti-polyNSV). 
The slices from day 5-10 (during the clearance of infectious virions) were also used for 
combined TUNEL-TSA, RNA FISH E1&E2 genes, and IF (anti-polyNSV) as described 
in Chapter 2. The largest slice (usually 3
rd
 one of total 5 slices, the section that contained 
hippocampus) of each mouse brain was imaged in 4 by 4 tile scan (objective lens 10x, 
zoom out 0.6, Zeiss LSM780FCS on Axio Observer Z1 inverted microscope). The digital 
files of the captured images were renamed so that the investigator did not know what 
group each file belonged to. The number of cells positive for Sindbis viral RNA, 
TUNEL, endogenous IgG, and IgM was counted manually, while the number for Sindbis 
viral protein was counted by set threshold in ImageJ software, because it was hard to 
determine the number of cells for both widely diffused and clumped viral proteins.  
Results: 
 Clinical outcomes are independent of antibody production. All four groups of 
mice had similar outcomes. Mortality rates were 5-10% (Figure 3.4A). Weight loss 
began on day 3-5, reached maximum at 1 week. The mice then regained weight and 
recovered the original weight at 2 weeks after infection (Figure 3.4B). The median day 
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of onset of clinical signs was day 5-6 (Figure 3.4D), was the worst on day 7-8, and then 
gradually improved. Recovery of DKO mice was a bit slower during the 3
rd
 week, but 
this was not statistically significant (Figure 3.4C). 
 Spinal cords do not require antibody for clearance of infectious virions, while 
brains need only 1 class of antibody. DKO mice were the only group failing to clear 
infectious virions from brain (Figure 3.5A). DKO mice had higher brain virus titers at 
the peak (day 3), delayed clearance (day 5-14), and then reactivated (day21 onward). In 
fact, few DKO mice did reduce infectious virus in brains to be below the detection limit 
of plaque assay at day 10, 14, 45, and 60. In brains, the sIgM-/- mice had an almost 
identical pattern of virion clearance to the WT mice, while AID-/- mice had lower peak 
levels of virus with a short delay in clearance. In spinal cords, all mouse groups could 
clear infectious virions with only some delay in DKO group (Figure 3.5B). 
 Antibody is not necessary for the early clearance of viral RNA either from 
brains or spinal cords. All mouse groups had similar initial viral RNA clearance, as 
assessed by RT-PCR for the SINV E2 gene, both from brains (Figure 3.5C) and spinal 
cords (Figure 3.5D). However, for DKO mice, the decrease in viral RNA stopped after 
day 30 in brains and day 45 in spinal cords, resulting in higher sustained viral RNA at 
late time points. 
 IFN-γ mRNA expression in spinal cords is the same for all groups, but DKO 
mice have lower early peak expression in brains. Unlike spinal cords, which have a 
gradual rise in IFN-γ mRNA expression (Figure 3.6B), in brains there is a prominent 
peak at day 5-7 after infection, except in DKO mice (Figure 3.6A). In DKO mice, the 
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pattern of IFN-γ mRNA expression in brains and spinal cords were indistinguishable. 
Except for the absence of the early peak in the brains of DKO mice, the IFN-γ mRNA 
expression was comparable in all mouse groups, both in brains and spinal cords. 
 AID mRNA expression in WT mice is higher than in sIgM-/- mice in both 
brains and spinal cords. The level of expression in brains (Figure 3.6C) was 10 times 
higher than in spinal cords (Figure 3.6D). The AID mRNA expression reached a plateau 
on day 7 and was maintained for 1 month after infection. 
 Earlier SINV-specific IgG in sIgM-/- mice and higher IgM in AID-/- mice 
than in WT mice. sIgM-/- mice produced levels of SINV-specific IgG comparable to 
WT mice in all specimens; sera (Figure 3.7A), brains (Figure 3.7B), and spinal cords 
(Figure 3.10D). In contrast, AID-/- mice produced much higher levels of SINV-specific 
IgM than WT mice in all specimens; sera (Figure 3.7C), brains (Figure 3.7C), and spinal 
cords (Figure 3.10C). However, only in sera, sIgM-/- and AID-/- mice produced earlier 
SINV-specific IgG and IgM, respectively, than WT mice. 
 sIgM-/- mice produce different subclasses of SINV-specific IgG from WT 
mice. Although total levels of SINV-specific IgG were similar, sIgM-/- mice had much 
higher levels of SINV-specific IgG2a, and lower levels of IgG1 and IgG2b than WT mice 
in all specimens; sera (Figure 3.8A-C), brains (Figure 3.9A-C), and spinal cords (Figure 
3.10A-B). Very little SINV-specific IgG3 is present in either sera (Figure 3.8D) or brains 
(Figure 3.9D). 
 Brain tissue imaging shows the same patterns and comparable numbers of 
infected cells during the clearance of infectious virions, day 5-10. Distribution 
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patterns of virus-infected cells are either in white or gray matter (see Chapter 2), 
independent of mouse group (Figure 3.11). The number of cells positive for viral 
proteins (Figure 3.12A) and viral RNA (Figure 3.12B) declined over day 5-10 and was 
comparable between groups. The number of apoptotic cells was highest on day 7 and was 
comparable between groups (Figure 3.12C). 
 The number of antibody-containing cells in brains is different between 
mouse groups. Both IgM-and IgG-containing cells infiltrated the infected brain foci and 
nearby thickened pia mater (Figure 3.13 and 3.14A). The number of these cells was 
quite different between the 4 mouse groups (Figure 3.14B). Infiltration of these cells was 
detected on day 10 for both IgG-positive cells and IgM-positive cells. WT mice had more 
IgM-positive cells than IgG-positive cells. After day 10,numbers of IgM-positive cells 
decreased rapidly in WT mice, but AID-/- mice retained large numbers of the IgM-
positive cells for much longer. Though sIgM-/- mice had almost no IgM-positive cells, 
they had the same pattern of IgG-positive cells as WT mice. DKO mice had exclusively 
IgM-positive cells that fluctuated in number throughout the infection. 
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 Immunoglobulin-deficiency does not affect clinical outcomes. In neuroadapted 
Sindbis virus (NSV), a fatal strain for immunocompetent mice, pathology is mediated by 
the immune response rather than the virus itself, because SCID mice can survive with 
persistent virus in CNS (94). This immunopathology is mainly caused by T-cells, not 
antibody (95). On the other hand, Sindbis TE strain rarely causes death in either immune 
competent or compromised mice. Wild-type and various immunodeficient mice (SCID, 
IFN-γ-deficient, μMT) can survive TE encephalomyelitis (43). Thus, the milder forms of 
immunodeficiency used in this study were unlikely to greatly impact outcomes. 
Nevertheless, DKO mice had some delay in recovery (Figure 3.4C). This can probably 
 74 
be explained by reactivation of the virus (Figure 3.5A) and prolonged infiltration of 
inflammatory cells (Figure 3.14B). 
 Either IgM or IgG alone is sufficient for clearance of infectious virions from 
brains. Similar to our study, IgM alone is enough to prevent mouse hepatitis virus (MHV) 
induced chronic demyelination in another study that used AID-/- mice (96). The higher 
SINV-specific IgM in AID-/- mice and the earlier IgG in sIgM-/- mice might compensate 
for the lack of another immunoglobulin class. The previously described characteristics of 
sIgM-/- mice, more IgG2a with less IgG1 and IgG2b (92), were also found in all 
specimens from our study. Even without antibody, a few DKO mice cleared infectious 
virions from the brains, though delayed. This suggests that antibody is barely needed for 
the clearance from the brains. In contrast, spinal cords, which produce much less 
infectious virions and viral RNA, can clear infectious virions in the absence of antibody. 
In fact, even SCID mice, which lack most adaptive immunity, can slowly clear the 
infectious virions almost completely from the spinal cords before reactivation (43). This 
is analogous to HIV infection, where each anti-retroviral drug has a limited ability to 
decrease the viral load. Only the combination of multiple drugs can suppress the virus 
enough to prevent emergence of escape mutants (97). In the same fashion, more aspects 
of immunity are probably needed for the higher burden of Sindbis virus in brains to 
suppress and prevent viral reactivation.  
 How can antibody that is not present in the brain during 1
st
 week help clear the 
infectious virions? SINV-specific antibody, that is already present in the plasma, might 
be responsible for the boost of IFN-γ expression in the brains on day 5-7, resulting in the 
better clearance. In humans, intravenous immunoglobulin (IVIG) can increase IFN-γ in 
 75 
plasma. Though no activated B or T-cells are observed in peripheral blood mononuclear 
cells (PBMC), there is an enhancement of Fc-γ receptor 1 (FcγRI) on monocytes (98). 
Because FcγRI has high affinity for IgG and can bind it in the absence of antigen, 
monocytes might engage SINV-specific IgG in the plasma before they infiltrate brain 
parenchyma, where they could help eliminate the virus. On the other hand, FcμR, which 
has high affinity for IgM (99), might be a major player in AID-/- mice.  
Another possibility is that antibody found in plasma during the 1
st
 week might 
have already reached the brain and helped clear the virus, but the excess amount of viral 
antigen might render the SINV-specific Ig-ELISA undetectable. Because the adoptive 
transfer of anti-SINV antibodies can clear infectious virions and viral RNA from SCID 
mouse brains (85), antibody in circulation must be able to reach the brain parenchyma, 
where the virus resides.  
 One major concern is that the DKO mice show higher infectious virions even with 
the same amount of viral RNA and infected cell count. Because cardiac perfusion with 
PBS might not completely wash out blood from the brain, virus might become 
neutralized by a small amount of natural or early SINV-specific antibody in the residual 
blood ex vivo during the homogenization. In agreement with this speculation, AID-/- 
mice, the only ones that produce SINV-specific antibody in sera as early as day 3, have 
the lowest peak on day 3 even with the same level of viral RNA as other groups. Another 
possibility is that the natural antibody in an inevitable bleeding during intracerebral 
injection might interfere the virus infection from the beginning, leading to the difference 
in peak amount of infectious virions. 
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 AID gene mRNA expression in both brains and spinal cords of sIgM-/- mice is 
lower than WT mice, while most immunoglobulin-producing cells in sIgM-/- mouse 
brains are IgG positive. Thus, class switching in sIgM-/- mice has already happened 
before the cells infiltrate the CNS. AID-/- mice retain the IgM-positive cells longer than 
WT mice. These cells stay in CNS longer and contribute to the local IgM production 
probably due to the inability of systemic IgM to cross blood-brain barrier (BBB). 
Interestingly, DKO mice cannot secret IgM but still have IgM-producing cells in the 
brain. Fluctuation in the number of these cells is probably a response to the reactivation 
of the virus. 
 In conclusion, immunoglobulin, regardless of its class, helps clear the infectious 
virions from brains but is not needed in spinal cords. Viral RNA clearance does not need 
antibody until very late. Antibody also has only subtle effects on clinical outcomes. 
Though antibody is very powerful in adoptive transfer and in vitro models, it reaches the 
CNS too late to have a major effect on clearance. Instead, antibody may play a more 
important role in prevention of viral reactivation. 
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Figure 3.1 Clearance of infectious virions in brains is different from spinal cords, where 
antibody is not required (complete clearance in μMT mice) (45).  
 
Figure 3.2 The plot shows the number of SINV-specific antibody-secreting cells (ASC) 
in brain suspensions from TE-infected C57BL/6 mice at various time points. IgG-ASCs 
infiltrate the brain later than IgM-ASCs (51).
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Figure 3.3 This bar chart shows the 450-nm optical density (OD) of total Ig-ELISA for 
1:400 diluted sera from different mouse groups. WT mice have both IgG and IgM, while 
DKO mice have none. AID-/- mice have very high IgM without IgG, and sIgM-/- mice 
have high IgG without IgM.
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Figure 3.4 Similarity in morbidity/mortality of SINV TE-infected mice from all 
groups; 4-6-week-old mice were inoculated intracerebrally with 1000 pfu SINV TE; A – 
Survival, B – Weight change, C – Clinical scores, and D – Onset of clinical signs. 
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Figure 3.5 Viral clearance. Plaque assay shows the virion clearance patterns for all 4 
mouse groups in brains (A) and spinal cords (B). RT-qPCR shows the viral RNA 
clearance in brains (C) and spinal cords (D). 
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Figure 3.6 IFN-γ and AID mRNA expression. RT-qPCR to determine the change (fold-
increase) from before infection (day 0) in IFN-γ mRNA in brains (A) and spinal cords 
(B) of all mouse groups. Because AID-/- and DKO mice do not express the AID gene, 




Figure 3.7 Production of SINV-specific antibody. The graphs show optical density 
(OD) of mouse sera (A and C), 1:100 dilution, and 20% brain homogenates (B and D), 
1:8 dilution, both tested for SINV-specific IgG-ELISA (A and B) and IgM-ELISA (C and 
D). P values represent the significance of difference between mouse groups by 2-way 
ANOVA. Asterisks show significant difference at particular time points (* p < 0.05, ** p 
< 0.01, *** p < 0.001) 
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Figure 3.8 The graphs compare the level of each IgG subclass in sera (1:100 dilution) 
between WT and sIgM-/- mice, detected by SINV-specific Ig-ELISA (A – IgG1, B – 
IgG2a, C – IgG2b, D – IgG3). P values represent the significance of difference between 
mouse groups by 2-way ANOVA. Asterisks show significant difference at particular time 




 Figure 3.9 The graphs compare the level of each IgG subclass in 20% brain 
homogenates (1:8 dilution) between WT and sIgM-/- mice, detected by SINV-specific Ig-
ELISA (A – IgG1, B – IgG2a, C – IgG2b, D – IgG3). P values represent the significance 
of difference between mouse groups by 2-way ANOVA. Asterisks show significant 





Figure 3.10 The graphs demonstrate the level of SINV-specific antibody in spinal cords 
by ELISA (A – IgG2a, B – IgG2b, C – IgM, D – IgG). P values represent the significance 
of difference between mouse groups by 2-way ANOVA. Asterisks show significant 




Figure 3.11 Combined TUNEL-TSA (green), RNA FISH E1&E2 genes (red), and IF of 
SINV proteins (white) on FFPE brain slices of representative 4 mouse groups during day 
5-10 shows the distributions of affected cells in cerebral cortex and hippocampus. 
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Figure 3.12 The graphs show number of cells positive for viral proteins (A), viral RNA 
(B), and TUNEL-TSA (C) per slice of right brain hemisphere during the clearance of 






Figure 3.13 The 4 by 4 tile scan image (stitching of 7 by 7 tile scan with 50% overlap) of 
the right hemisphere of a WT mouse, 10 days post-infection, shows the distribution of 
cells with viral proteins (white), mouse IgG (red), and IgM (green). 
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Figure 3.14 A – Higher power 
examination of figure 3.13 WT mouse 
brain reveals the Ig-positive cells (IgG –
red, IgM – green) infiltrating pia mater 
and infected brain parenchyma (white).  
B – Graph of the number of IgM- and 
IgG-positive cells per slice of right brain 





Sindbis Virus with Fluorescent RNA Aptamers 
Introduction: 
The regulation of viral RNA synthesis and degradation in infected cells by 
cellular and immune factors is poorly understood. To facilitate studies of viral RNA 
dynamics during infection and immune-mediated clearance, we sought to develop SINV 
RNA that could be visualized in live cells.  
Although techniques for fluorescent tagging and visualization of viral proteins 
during replication (e.g. with green fluorescent protein [GFP]) are well established, 
visualization of viral RNA has been more challenging. Approaches have included 
fluorescent antisense probe hybridization and molecular beacons that rely on probe 
delivery into the cells. In addition to methods for detecting unmodified RNA, RNAs have 
also been engineered to facilitate detection by inserting repeats that bind GFP-tagged 
bacteriophage MS2 protein or inserting aptamers that bind a fluorophore (100).  
Recently, the Spinach RNA aptamer and its more stable derivative Spinach2 have 
been inserted into RNA and used in combination with derivatives of the GFP-related 
conditional fluorophore 4-hydroxybenzidine imidazolinone (HBI) to visualize RNA in 
live cells (101, 102). The Spinach2 aptamer is a 97 nt RNA stabilized within a tRNA 
scaffold (103) that can be inserted into an RNA of interest.  When the cell-permeable 
non-toxic conditional fluorophore 3,5-difluoro-4-hydroxybenzylidene imidazolinone 
(DFHBI), DFHBI-1T, or DFHBI-2T binds the RNA aptamer, it becomes activated with 
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emission of green fluorescence upon excitation that allows live cell visualization of RNA 
abundance and localization (101, 104, 105) (Figure 4.1).  This system has been used to 
tag and image cellular RNAs (101), but has not previously been applied to viral RNA. 
For visualization of SINV RNA, we inserted 1 to 2 Spinach2 aptamers into full-
length SINV TE cDNA clones either into the 3’UTR or behind a second subgenomic 
promoter and recovered viruses that could be used to study the dynamics of viral RNA 
replication and distribution as well as antibody-mediated clearance in live cells. 
Later on, tRNA-Spinach2 had been replaced by the brighter and smaller new 
RNA-aptamer, Broccoli, in more stable F30 scaffold (106-108) (Figure 4.1). We inserted 
4 to 28 Broccoli aptamers at the same sites as Spinach2 (see above). Unlike tRNA-
Spinach2, F30-Broccoli does not contain any stop codons and therefore can be inserted 
into the nsP gene for visualization of viral genomic RNA. When Broccoli binds to the 
fluorophores, it can emit similar fluorescence patterns to Spinach2. 
Table 4.1 Maximal excitation/emission wavelength for each aptamer-fluorophore 
combination (104, 108) 
 
Materials and Methods: 
In vitro signal and specificity of Spinach2-DFHBI. The pET28c-Spinach2 
plasmid that contained Spinach2 within a tRNA scaffold (103) was a gift from Samie 
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Jaffrey (Weill Cornell Medical College, New York) (102).  Spinach2 scaffolded by tRNA 
was amplified by Taq-polymerase PCR and ligated to the overhung T ends of the PCR II-
TOPO vector (Invitrogen). After linearization of the plasmid with BamHI (New England 
Biolabs), Spinach2 with the tRNA scaffold was in vitro transcribed with T7 Maxiscript 
(Ambion).  4 μg of Spinach2 transcript (1 μM: 3.01 X 10
13
 copies/well) and 4 μg of RNA 
extracted (RNeasy lipid tissue mini kit, Qiagen) from TE-infected (3 days) and 
uninfected mouse brains, were incubated in 50 μl of buffer containing 40mM HEPES 
(Gibco), 100 mM KCl, and 1 mM MgCl2 with or without DFBHI 10 μM for 30 min at 
37
O
C. Fluorescent signal intensity was measured at Ex447/Em501 with a fluorescence 
plate reader (SpectraMax). 
Construction of SINV-Spinach2 (Figure 4.2). Spinach2 within the tRNA 
scaffold was inserted into the either the TE (24) or TEds (double subgenomic) (109) full 
length SINV plasmid. The insertion sites were the BstEII restriction site downstream of 
the second subgenomic promoter or an SphI site in the 3’UTR produced by site-directed 
mutagenesis. The four constructed SINV plasmids were TEds1xSpinach2 (TEds-1Sp), 
TEds2xSpinach2 (TEds-2Sp) with 1 or 2 copies of Spinach2 after the second subgenomic 
promoter; TE-3’UTR1xSpinach2 (TE-1UTRSp) with one copy of Spinach2 in the 3’UTR 
and TEds1x-3’UTR1xSpinach2 (TEds-1Sp+1UTRSp) with a copy both downstream of 
the subgenomic promoter and in the 3’UTR.  
Construction of SINV-Broccoli (Figure 4.3-4.4). F30-2xdBroccoli, a double 
dimeric Broccoli (4 copies in total) in F30 scaffold from pET28c plasmid (Addgene 
66843) was inserted into SphI and/or BstEII sites (see above). Due to the lack of a stop 
codon, F30-2xdBroccoli was also inserted into the SpeI site of the nsP3 gene. The 
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constructed plasmids were TEds6xBroccoli (TEds6Br; the ligation resulting in 1½ sets of 
F30-2xdBroccoli for an unclear reason), TE3’UTR4xBroccoli (TE-UTR4Br), TEds6x-
3’UTR4xBroccoli (TEds10Br), TEnsP3-4xBroccoli (TEnsp3-4Br), TEnsP3-8xBroccoli 
(TEnsP3-8Br), and TEnsP3-4x-ds6x-3’UTR4xBroccoli (TEds14xBr). Furthermore, we 
made a tandem repeat as described by Jobbagy et al (110). Briefly, BamHI and BglII 
restriction sites were added to the 5’ and 3’ ends of F30-2xdBroccoli, respectively, so that 
it could be self-ligated by these 2 compatible sites and formed tandem repeats. The strips 
of BstEII-SphI-SpeI restriction sites were also added to both ends of the tandem repeats. 
The largest contained 3 sets of F30-2xdBroccoli (12 copies). This 12xBroccoli was 
inserted into each of the 3 restriction sites. Unfortunately, we could not recover the 
correct insertion of 12xBroccoli at the 3’UTR site. Thus, the maximal number of 
Broccoli we could produce was 28 copies in TEnsP3-12x-ds12x-3’UTR4xBroccoli 
(TEds28xBr). 
In vitro transcription and transfection. All constructed plasmids were 
sequenced to confirm the correct insertions and orientations. mRNA of each construct 
was produced by Sp6 mMessage mMachine (Ambion) after linearization of the plasmid 
with XhoI (New England Biolabs). 200 μl Opti-MEM (Gibco) with 20 μg of each mRNA 
was mixed into another 200 μl Opti-MEM containing 40 μl Lipofectamine 2000 (Life 
Technologies). After adding 3.6 ml Opti-MEM, the total mixture was applied to nearly 
confluent BHK cells in a T150 flask, washed with phosphate buffered saline (PBS), and 
incubated at 37
O
C 5% CO2 for 4 h with intermittent rocking. The transfection mixture 
was then replaced by 12 ml of infection medium (see below). At 24 h, the supernatant 
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fluids were collected and frozen in aliquots at -80
 O
C. Titers of the recombinant viruses 
were determined by plaque assay (see below). 
Cell culture, differentiation, and infection (Figure 4.5).  BHK cells were 
cultured at 37
O
C 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM, Gibco) with 
10% heat-inactivated fetal bovine serum (FBS, Atlanta Biologicals), 1% PenStrep (PS, 
Gibco), and 2mM glutamine (Gibco). AP7 rat olfactory neurons transformed with a 
temperature-sensitive SV40 T antigen (111), were either maintained as cycling cells 
(cAP7) at 33
O
C 7%CO2, or were differentiated (dAP7) by adding 1 μg/ml insulin 
(Sigma), 100 μM ascorbic acid (Sigma), and 20 μM dopamine (Sigma) and culturing at 
39
O
C 5%CO2 for 7 days. Nearly confluent cells were infected with the recombinant 
viruses in infection medium at a multiplicity of infection (MOI) of 0.01 to 20. 
Live-cell imaging. Cells were grown on glass-bottom 35mm dishes, 24-well 
plates (Mattek), or 8-well chamber slides (Labtek).  Infected cells were imaged after 
incubation with 20 μM DFHBI or DFHBI-1T (Lucerna) in imaging medium (Fluorobrite 
[Gibco], 25mM HEPES [Gibco], 5mM MgSO4, 1%FBS) at 37
O
C for 30 min. For time-
lapse imaging, 1% FBS, 1% PS, and 2mM glutamine were also added to the imaging 
medium. Maximal excitation/emission for DFHBI- and DFHBI-1T-Spinach2 complexes 
are 447/501 and 482/505, respectively (112). Because of compatibility with the imaging 
system, most images were obtained using DFBHI-1T. In each imaging session, the laser 
power and gain were adjusted to minimize autofluorescence from TE (no aptamer) -
infected cells. A 488nm laser was used for excitation of Spinach2- or Broccoli-
fluorophore complexes in confocal microscopic imaging (Zeiss LSM780CS, Axio 
Observer Z1, Zen Software). When the signal overlapped with autofluorescence, the 
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lambda mode was used to capture emission spectrum of each pixel in the image. Because 
the emission spectra were different, Spinach2 and Broccoli could then be separated from 
autofluorescence by linear unmixing (Zen Software). Time-lapse experiments were 
performed in a heated chamber at 24% humidity using the same temperature and CO2 
levels as the culture conditions for each cell type. Images were analyzed with ImageJ 
Software. 
Flow cytometry. Infected and uninfected BHK cells with or without treatment 
were trypsinized, resuspended in the imaging medium and incubated with or without 
fluorophores at 37
O
C for 30 min. Cell suspensions were filtered through 70μm nylon 
filter (Cell strainer, Falcon). Data were acquired on a BD FACS Canto II flow cytometer 
in the GFP/FITC channel and analyzed with FlowJo (TreeStar). 
Directed viral evolution. BHK cells were infected with dsTE-1Sp+1UTRSp at 
an MOI of 1 at 4
o
C for 1 h with rocking every 10 min to allow viral binding but not 
endocytosis. The cells were then shifted to 37
O
C for synchronous virus entry.  At 6 h, 
infected cells were sorted in a Beckman Coulter MoFlo Cell Sorter based on brightness in 
the FITC/GFP channel at 488nm excitation.  Single cells were sorted into wells of 96- or 
48-well plates pre-seeded with BHK cells in DMEM-1%FBS. After overnight incubation, 
supernatant fluids were collected and infected cells in each well were trypsinized and 
incubated with imaging medium for flow cytometry to determine signal intensity. Viruses 
in supernatant fluids from wells containing cells with the strongest signals were expanded 
in BHK cells and quantified by plaque assay. The expanded viral clones were retested for 
fluorescent signal and the brightest clones were chosen for another round of selection by 
cell sorting.  
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Virus replication and plaque purification. To assess virus replication, BHK, 
cAP7, and dAP7 cells were infected in triplicate at an MOI of 5. Supernatant fluids were 
collected at 3, 6, 9, 12, 18 and 24 h for plaque assay.  Plaque assays were performed 
using nearly confluent BHK cells in 6-well plates incubated with 200 μl of 10-fold serial 
dilutions of each sample in DMEM+1%FBS for 1 h at 37
O
C 5%CO2 with rocking every 
10 minutes. The samples were replaced with 1.5ml of agar (0.6% Bactoagar, 1x 
minimum essential medium (MEM, Gibco), 1%FBS) and returned to the incubator. After 
48 h, cells were stained with neutral red (Sigma) in Dulbecco’s PBS with calcium and 
magnesium (DPBS, Lonza) for 2 h at 37
O
C 5%CO2 and plaques were counted.  For 
plaque purification the agar over a plaque was aspirated, re-suspended in 100 μl PBS, 
kept at 4
O
C overnight and then propagated in BHK cells.  
Agarose gel electrophoresis. Viral RNA from infected BHK supernatant fluids 
following transfection, sorting, and plaque purification, was amplified by RT-PCR. The 
PCR products were separated by agarose gel electrophoresis, stained with ethidium 
bromide and captured with Gel Doc (Bio-Rad). Some bands were selected for 
sequencing. 
Treatment of infected cells with antibody. SV127 (209; mouse monoclonal 
neutralizing IgG3 against SINV E2) (113) from hybridoma supernatant was purified by 
Melon Gel IgG Purification Kit (Thermo Scientific), quantified by Pierce BCA Protein 
Assay Kit (Thermo Scientific), and then conjugated with Dylight 594 Antibody Labeling 
Kit (Thermo Scientific), according to the manufacturer’s respective protocols. BHK, 
cAP7, or dAP7 cells were infected with one of the constructed viruses at an MOI of 5-20. 
The cells were treated with 1-5 μg/ml of SV127, Dylight594-conjugated SV127 (~5 
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dyes/IgG molecule), or 500 U/ml of rat IFN-γ at various time points for either imaging or 
flow cytometry. TrkA antibody (Clone 315104, R&D Systems) at 1μg/ml was used as a 
control.  
In vivo study. TE, TE3’UTR1xSpinach2, TEds1x-3’UTR1xSpinach2, 1a5, 1b6, 
1c6 (the brightest three viral clones from second sorting), and all SINV-Broccoli were 
used for infection of mice.  A couple of C57BL/6 mice, 2-3 months old, were 
intracerebrally injected with 1000 pfu/20 μL of each virus. At day 3, brains were 
collected and the left anterior quadrant was homogenized with 1 ml PBS in Lysing 
Matrix A tubes in a FastPrep-24 machine (MP Biomedicals) at 6 m/sec speed for 40 sec 
to make 10% brain homogenates for plaque assay. 
Results: 
Spinach2 experiments 
The fluorophore does not form fluorescent complexes with non-specific 
RNAs. To determine specificity of the fluorescent signal, in vitro transcribed Spinach2 
RNA was analyzed with and without added DFHBI. RNA fluorescence required DFHBI 
and was concentration-dependent. RNA extracts from SINV-infected and uninfected 
mouse brains were used to assess nonspecific fluorescence of RNA without Spinach2 in 
the presence of DFHBI. These controls showed no signal higher than the buffer-only 
control (Figure 4.6A).  Flow cytometry was used for analysis of BHK cells infected with 
TEds-1Sp+1UTRSp with and without exposure to DFHBI (Figure 4.6B). The shift of 
signal from baseline in the GFP/FITC channel occurred only when cells were infected 
with virus that contained Spinach2 in the presence of DFHBI. 
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Imaging the Spinach2-fluorophore signal in infected cells. Cells infected with 
Spinach2 recombinant viruses and incubated with DFHBI showed little signal when 
viewed in the epifluorescence microscope and prolonged exposure was not possible due 
to rapid bleaching. Because the signals revived after resting with excess fluorophore in 
the medium, it was hypothesized that pulse excitation would improve the signal to noise 
ratio (114). A laser-scanning confocal microscope provides such pulses because the 
excitation laser hits each tiny point for just few microseconds during each scanning 
frame, leading to a very short exposure with a very long rest. Multiple repeated scans on 
the same frame could therefore be averaged to improve the resolution or summed to 
increase the signal intensity without photobleaching.  The signal was sufficient for Z-
stack (Figure 4.7) and time-lapse imaging. 
Effect on fluorescence of the fluorophore and copies of Spinach2. Cells 
infected with TEds-1Sp+1UTRSp gave the strongest signal both in flow cytometry and 
microscopic imaging (Figure 4.8), followed by TE-1UTRSp and TEds-1Sp. Surprisingly, 
TEds-2Sp was less bright than either of the viruses with only one copy of Spinach2. The 
fluorophore DFHBI-1T is more compatible with available laser and filter sets (104) and 
provided a better signal than DFHBI in our studies (Fig 4B). DFHBI-1T readily enters 
cells and the intracellular SINV-RNA-Spinach2 signal reached peak intensity within a 
few minutes after addition (Figure 4.9). 
Effect of Spinach2 on virus replication. The effect of Spinach2 tagging on virus 
replication was assessed in generally permissive BHK and cAP7 cells and in more 
restrictive differentiated dAP7 cells (Figure 4.10) (28, 115). Insertion of Spinach2 into 
the 3’UTR had no effect on replication while insertion after a second subgenomic 
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promoter generally impaired replication. In particular, replication of TEds-2Sp was 
reduced 10-20-fold in BHK and cAP7 cells compared to the parent TE virus, although 
this was not evident in less permissive dAP7 cells.  
Directed viral evolution improves the brightness of SINV-Spinach2. To select 
for the brightest viruses TEds-1Sp+1UTRSp-infected BHK cells were sorted by FACS 
(Figure 4.6) for the 15 brightest cells out of 15,000 events (1:1000). Viruses originating 
from these bright cells were expanded, quantified, and retested for signal intensity in 
BHK cells. The 1d11 clone was selected for 2
nd
-round sorting, because the brightest 
clone (1c9) did not replicate well.  In the 2
nd
 round sort with 1d11-infected BHK cells, 
propidium iodide exclusion was used to include only single live cells. The 53 brightest 
cells were sorted from 17 million events (1:300000). The twelve brightest viral clones 
were expanded, quantified, and retested for signal intensity.  Clone 1a5 had a signal 68% 
brighter than the original TEds1x-3’UTR1xSpinach2 (Figure 4.8), without a difference 
in replication in either BHK or dAP7 cells (Figure 4.10).  Sequencing from the second 
subgenomic promoter to 3’ end of 1d11 and 1a5 showed point mutations only in the 
tRNA scaffold (Figure 4.12). 
Viruses with two Spinach2 copies were unstable. Gel electrophoresis of RT-
PCR products of viral RNA extracted from transfection supernatant fluids showed a 
single band with the correct length in the viruses that had only 1 copy of Spinach2. 
However, TEds-2Sp had 3 bands consistent with deletion of one copy of tRNA-Spinach2 
and TEds-1Sp+1UTRSp and 1a5 (not shown) had 2 bands, the correct length and a 
shorter one due to a large deletion (341 bases). The deletion included 1 copy of tRNA-
Spinach2 (168 bases) and a part of the 3’UTR. Plaque purification could not separate 
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viruses with full-length RNA from those with the deletion as 2 bands were present in all 8 
viral clones purified from TEds-1Sp+1UTRSp (Figure 4.12). 
SINV-Spinach2 viruses were attenuated in vivo. To determine the ability of the 
Spinach2-tagged viruses to replicate in vivo, we infected two 2-3 month old C57BL/6 
mice intracerebrally with 1000 pfu TEds -1Sp+1UTRSp and derivative clones 1a5, 1b6, 
or 1c6, along with TE (Figure 4.11). Brain homogenates collected 3 days after infection 
were assayed for infectious virus in BHK cells. All mice infected with TE were positive 
for virus, but no brains from mice infected with clones and only one brain from mice 
infected with TEds-1Sp+1UTRSp had infectious virus.  The virus from this mouse 
retained its fluorescence after recovery in BHK cells. 
Use of SINV-Spinach2 viruses for evaluation of viral RNA dynamics, 
distribution, and antibody-mediated clearance. Live-cell imaging of BHK cells 
infected with TEds-1Sp+1UTRSp allowed analysis of the onset of viral RNA replication 
in individual cells and spread in the culture (Figure 4.13). Interestingly, infected cells 
concentrated viral RNA at the tip of filopodia that contacted adjacent non-infected cells. 
Viral RNA was subsequently observed in the contacted cell, starting at the contact site 
followed by spread throughout the cytosol (Figure 4.13).  Addition of neutralizing anti-
SINV E2 antibody to infected BHK cells did not inhibit spread of the virus to adjacent 
cells and increased the amount of intracellular viral RNA (Figure 4.14).  
cAP7 cells could also be imaged after infection with TEds-1Sp+1UTRSp and 
antibody-treatment resulted in clearance of viral RNA (Figure 4.15). The anti-SINV E2 
(SV127-Dylight594) bound the infected cell membrane more intensely with longer 
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incubation. With more antibody binding, the less viral RNA (Spinach2 signal) could be 
found intracellularly. 
Spectral imaging can differentiate the overlap between low Spinach2 signal 
and high autofluorescence in differentiated neuronal cells. SINV replication is 
restricted in differentiated neuronal cells (Figure 4.11) (28, 115) so levels of viral RNA 
are lower in infected dAP7 cells than BHK and cAP7 cells. With low viral RNA copy 
number in infected dAP7 cells, the Spinach2 signal intensity from TEds-1Sp+1UTRSp 
was very close to the autofluorescence associated with differentiated neurons.  Spectral 
imaging showed a 505nm emission peak from Spinach2 and a smooth autofluorescence 
curve. Linear unmixing revealed the perinuclear autofluorescent granules and the viral 
RNA accumulated at the tips of dendritic-like processes (Figure 4.16). Live-cell imaging 
of antibody-treated infected dAP7 cells demonstrated an inverse correlation between the 
amount of antibody bound to the cell surface and amount of viral RNA (Figure 4.17). 
Broccoli experiments 
 Once the far superior Broccoli RNA aptamer was available, we replaced 
Spinach2-labeled SINV with Broccoli-labeled SINV for our experiments. 
 The signal intensity was correlated with the number of Broccoli copies 
(Figure 4.18). The F30-2xdBroccoli is much brighter than tRNA-Spinach2. From 4 to 14 
copies, the signal intensity increased according to the copy number. However, TEds28Br, 
which had tandem repeats of F30-2xdBroccoli, did not show a brighter signal than 
TEds14Br. Because the TEnsP3-4Br and TEnsP3-8Br had Broccoli in genomic RNA 
only, they were dimmer than those that had Broccoli in subgenomic RNA. 
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 Broccoli signal can survive fixation (Figure 4.19). Unlike Spinach2, fixation 
with 3.7% paraformaldehyde at room temperature for 10 minutes did not obliterate the 
Broccoli signal. However, fixation did decrease the signal intensity and also increased 
autofluorescence. Thus, live-cell imaging gave a better signal to noise ratio than fixed 
cell imaging. 
 Broccoli signal was colocalized with SINV RNA FISH (Figure 4.20). Post 
fixation imaging showed almost identical patterns between RNA FISH and Broccoli 
signal (Rcolocalization = 0.9049). In TEds10Br, discrepancy between the 2 signals did rarely 
occur in a few cells from the whole well (~32000 cells/well) (Figure 4.21). Because for 
TEds10Br Broccoli was inserted into the second subgenomic site, the discrepancy might 




 subgenomic promoter of the 
virus in those particular cells. However, this phenomenon was very rare and should not 
affect the outcome of experiments. 
 Broccoli can be used in differentiated neurons. Spinach2 gave very dim signal 
in dAP7 cells. The spectral imaging (lambda mode) could differentiate the signal from 
autofluorescence (see above) only in few dAP7 cells, while most of the infected cells did 
not have enough signal, making it very hard to use in experiments. In contrast, Broccoli 
was bright enough to be seen in most infected dAP7 cells (Figure 4.22), though lambda 
mode was still needed. The Broccoli signal could also be observed directly through a 
glass-bottom dish with a brain slice from a mouse, sacrificed on day 3 post intracerebral 
injection with TEds10Br (Figure 4.23). However, a Transwell insert obscured the 
Broccoli signal; thus, it was not ready for ex vivo brain slice culture experiments yet. 
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 Attenuation of SINV with high copy number of Broccoli in differentiated 
neurons (Figure 4.24). TE3UTR4Br and TEds6Br replicated very well in all types of 
cells and in mouse brain. On the other hand, TEds10xBr, TEds28Br, and the worst 
TEds14Br replicated poorly in dAP7 cells and mouse brains, but quite well in BHK and 
cAP7 cells. TEnsP3-4Br and TEnsP3-8Br replicated well in all types of cells, but 
inconsistently in mouse brains from very low to very high number of pfu. 
 SINV genomic viral RNA form vesicle-like arrangement in perinuclear area 
(Figure 4.25-4.26).  Unlike subgenomic Broccoli, genomic Broccoli clearly accumulated 
close to the nucleus and assumed a circular shape with an inside halo. This halo could 
contain either viral envelope protein or mitochondrion (Figure 4.27). Time-lapse imaging 
of merged phase contrast-Broccoli (Figure 4.28) showed many vesicles surrounded with 
SINV genomic RNA were gathered around the perinuclear halo (most likely golgi 
apparatus). Later on, the genomic RNA was accumulated in the halo and formed another 
vesicle-like arrangement. 
 Antibody treatment enhanced viral replication and altered the distribution of 
genomic RNA in BHK cells. The rate of viral replication depended on the multiplicity of 
infection (MOI) and was increased by anti-E2 [SV127] treatment in BHK cells (Figure 
4.29). The genomic RNA distribution was also changed from accumulation at perinuclear 
area to cell membrane upon antibody treatment (Figure 4.30). 
 Antibody and IFN-γ mediated viral RNA clearance and improved survival in 
dAP7 cells. In contrast to BHK cells, dAP7 cells could clear the viral RNA during 24-72 
hours post infection upon treatments with either anti-E2 [SV127] or IFN-γ. Both 
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treatments also improved cell survival, especially in combined treated cells (Figure 
4.31). However, viral RNA still persisted in a few cells, to which anti-E2 could not bind 
(Figure 4.32). These cells still had intracellular E2 protein, but lacked its expression on 
the cell membrane (Figure 4.33). Flow cytometry on infected dAP7 cells with similar 
treatments confirmed the live-cell imaging finding (Figure 4.34). However, neither 
antibody nor IFN-γ treatment showed any benefits on BHK cells, while only antibody 
could mediate virus clearance in cAP7 cells and did not improve  survival (Figure 4.35).  
Discussion: 
The successful examples of Spinach labeling are the abundant 5S-ribosomal RNA 
(10
7 
molecules/cell) and CGG-triplet repeat (101, 102). The remarkably lower number of 
SINV RNA molecules per cell (Table 4.2) and low signal intensity of the aptamers 
become a challenge. Spinach2 can only be used for live-cell imaging of subgenomic 
RNA in undifferentiated cells. Though not completely covering all the aspects, the 
brighter Broccoli can be applied to fixed cells, genomic RNA, differentiated cells, and ex 
vivo brain slices (Table 4.3). 
Table 4.2 The amount of Sindbis viral components in undifferentiated cell lines 





  (116) 
Subgenomic RNA 5 X 10
5
  
Genomic RNA 1.6 X 10
5
  (117) 
dsRNA/minus-stranded RNA 2.7 X 10
4
  (118) 
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Table 4.3 The applications of SINV-aptamers 
 
More copies of Spinach2 may not always result in the stronger signal. TEds1x-
3’UTR1xSpinach2, into which each Spinach2 copy has been inserted separately at 2
nd
 
subgenomic promoter and 3’UTR sites, shows the best signal. On the other hand, 
insertion of 2 Spinach2 copies together as tandem repeats at 2
nd
 subgenomic promoter 
site in TEds2xSpinach2 gives the dimmest signal. This is at least partially due to its 
inferior replication in BHK cells. Since tRNA-Spinach2 contains many stop codons in all 
frames, it is hard to find more sites to accommodate the 3
rd
 copy and beyond. 
After 2 cycles of the brightest viral clone sorting by FACS, 1a5 clones remarkably 
increases the signal intensity from the original one. The clone shows comparable 
replication in 1-step viral growth curve; thus, the better signal is likely due to the better 
RNA-folding stability. We cannot find 1a5 a new mutation in Spinach2-tRNA sequence, 
added to its parental clone, 1d11. Thus, mutations outside Spinach2-tRNA may 
contribute to the stability too.  
Any proteins, RNA aptamers, or promoter sequences that can be coded into viral 
genome and have their properties quantified by flow cytometry or other types of cell 
sorting may also get benefits from this “Directed Viral Evolution” as long as the 
constructed viruses can replicate. For instance, one may insert a fluorescent protein gene 
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into TEds and use FACS to sort the cells with stronger signal or spectral shift. Each 
round takes about 1 week, so we can make the virus evolve rapidly until the signal 
reaches its maximum. Sequencing of the virus will reveal the new desired version of the 
fluorescence protein. This is similar to the way Broccoli RNA has been discovered (108), 
except the mutation and the sorting are done in a single step. However, the mutations that 
limit replication will not be selected. We may also overcome the attenuation in vivo by 
passage the virus between mouse brains and cell cultures instead of cell cultures only.  
Though their signals are improved, TEds1x-3’UTR1xSpinach2 and its mutants 
are not stable. There are always 2 viral populations with different genome sizes, the 
correct sequence and the large deletion. The large deletion persists in all viral clones that 
arise from plaque purification. Thus, the large deletion most likely occurs naturally 
during the viral replication and cannot be avoided. Homologous recombination and 
intracellular cleavage of tRNA scaffold might be the causes (107). 
F30-2xdBroccoli is much brighter than tRNA-Spinach2. Unlike tRNA, F30 
scaffold is not a target of intracellular cleavage (107). However, Broccoli still suffers the 
similar fates as Spinach2. Too many copies of Broccoli attenuated the viruses in vivo and 
may not improve the signal. 
SINV with fluorescent RNA aptamers can be used in many applications, where 
RT-PCR and FISH techniques are not very useful. In live-cell imaging, we can quantitate 
the relative amount of viral RNA in each cell/organelle and visualize its distribution. We 
can see viral RNA clearance, mediated by antibody or interferon, in real time. 3D 
reconstruction can be done to see colocalization or FRET with viral or host proteins, 
labeled with fluorescent proteins. For ex vivo studies, we may infect mice, making single-
 107 
cell suspensions from their infected tissues, and then count or sort aptamer-positive cells 
with FACS to further study these naturally infected cells outside the bodies.  
In this study, we can demonstrate at least two types of vesicle-like genomic RNA 
arrangement in live cells. The one found earlier is most likely the endosome-derived 
cytopathic vacuole (CPV) type I, which contains viral replication complex (19). The 
genomic RNA that surrounds this vacuole might be nascent produced from the replication 
complex inside. Another one, found later in the perinuclear halo, is probably the trans 
golgi apparatus-derived CPV type II, which contains envelope proteins and is surrounded 
by viral nucleocapsid (15). Furthermore, we also find that some of these genomic RNA 
encircled mitochondria, which haven’t been documented before. The mitochondria stop 
moving after being encased by the viral genomic RNA, which might be the process of  
mitophagy. 
 Our study with SINV-aptamer also reveals vast different effects of antibody and  
IFN-γ treatments on different cell types as shown by both live-cell imaging and flow 
cytometry (Table 4.4). Both replications (Figure 4.24) and clearance patterns of viruses 
in dAP7 cells represent in vivo study in mouse brains quite well. Similar to mouse study 
in Chapter 2, the viral RNA persists in cells that antibody cannot bind, possibly due to 





Table 4.4 Summary of treatments on different types of cells 
 
 The production of Sindbis-fluorescent RNA aptamers will be the early step of 
new approaches toward viral RNA study. With our best clone, we still cannot use it for ex 
vivo brain slice culture. The dim signal that overlapped with autofluorescence is the main 
problem. This can be partially overcome by separating the different emission spectra 
between aptamer-fluorophore and autofluorescence with linear unmixing. Low amount of 
viral RNA is still a challenge. New fluorophores are under development toward emission 







Figure 4.1 Principle of fluorescent RNA aptamers . Green fluorescent protein (GFP) 







, encased in β-barrel (A). The β-barrel is critical to the signal emission, since 
it restrains the fluorophore and thus prevents energy lost through the movement of the 
excited fluorophore. The GFP fluorophore (HBI) can be synthesized and modified to 
imitate enhanced GFP (eGFP). This modified fluorophore (DFHBI) can permeate into the 
cells and emit fluorescence upon excitation after binding to the RNA aptamers (B), which 
act like the β-barrel. Various RNA aptamer-fluorophore combinations give different 
fluorescence spectra (C and D, red circle – Spinach-DFBHI). Spinach2 has a better 
folding stability over Spinach due to few point mutations (B). Broccoli was subsequently 
developed (E). It is smaller and has a better signal than Spinach2. Image E shows a 
Broccoli monomer in a tRNA scaffold, Broccoli dimer (dBroccoli), and Broccoli 
monomer in a F30 scaffold. F30 is more stable than tRNA. It has 2 arms – each can 
accept a set of Broccoli dimer, thus can contain 4 Broccoli at maximum (F30-
2xdBroccoli). The example of constructed viral RNA genome, F30-2xdBroccoli insertion 
at 3’UTR, is shown inside the infected cells (F). The 4 copies of Broccoli RNA aptamers 
bind the permeable fluorophore, added to the medium, and emit green fluorescence upon 





Figure 4.2 Construction of Sindbis virus-Spinach2. The tRNA-Spinach2 sequence was 
inserted into the plasmids of either TE or TEds (the underlined sequence added to TE) 
downstream of the 2
nd
 subgenomic promoter (bold characters) at the BstEII site (green 












Figure 4.3 F30-2xdBroccoli (A) and construction of tandem repeats. The sequence 
(A) shows 2 copies of Broccoli dimers (bold green characters) in F30 scaffold (black 
characters). The tandem repeats (B) consist of 3 sets of F30-2xdBroccoli (12 Broccoli in 
total), made from self-ligation between the complementary 5’ (BamHI – G^GATC_C) 
and 3’ end (BglII – A^GATC_T). The ligation forms a scar (GGATCT), which can no 
longer be cut by both BamHI and BglII. The tandem repeats can be cut and inserted into 3 
restriction sites of TEds plasmid in the specific order – nsP3, 3’UTR, and downstream of 
2
nd





Figure 4.4 Construction of SINV-Broccoli. The F30-2xdBroccoli, 1-3 repeats, has been 
inserted into 3 restriction sites – SpeI in nsP3, BstEII downstream of 2
nd
 subgenomic 
promoter, and SphI in 3’UTR. 
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Figure 4.5 Types of cell lines used in this study. The table shows the culture conditions 
and characteristics of each cell line. The images show green fluorescence from 







Figure 4.6 Specificity of Spinach2-fluorophore signal. (A) The bar chart showed 
specific concentration-dependent signal intensity of in vitro Spinach2 RNA transcript at 
0.5 and 1 μM (4μg/well) in the presence of DFHBI. Non-specific RNA from brain 
extracts (4μg/well) had the same level of signal as the buffer only control. (B) Analysis of 
uninfected and TE- or TEds-1Sp+1UTRSp-infected BHK cells (MOI=1, 6 h after 
infection) by flow cytometry in PI (propidium iodide, Y axis) and GFP (green fluorescent 
protein, X axis) channels. Only when both the Spinach2 sequence and DFHBI were 
present (right lower panel) was fluorescence in the GFP channel detected. Cells in the 
small inset (R8) in the right lower panel were brightest and were sorted to select for viral 





Figure 4.7 Viral RNA distribution. The orthogonal view of live-cell imaging showed 
the XY and cross-sectional view of viral RNA distribution in the cytosol of TEds1x-
3’UTR1xSpinach2-infected BHK cells incubated with DFHBI-1T. (Z-stack imaging, 










Figure 4.8 Signal intensity of TE-Spinach2 viruses. Live-cell imaging of infected BHK 
cells (MOI 5, 20 hours, objective lens 10x) showed relative fluorescence intensity of 
TEds2xSpinach2< TEds1xSpinach2< TE3’UTR1xSpinach2< TEds1x-3’UTR1xSpinach2. 
The signal was further improved for viruses selected in the 1
st
 sort (1d11) and 2
nd
 sort 
(1a5). (A) All images were taken in the presence of DFHBI-1T, except the 1
st
 panel in the 
lower row where the cells were incubated with DFHBI. DFHBI-1T provided a far 
brighter signal with excitement from the 488nm laser than DFHBI. (B) Bar chart of mean 
signal intensity after subtraction of mean fluorescence of uninfected cells (~25,000 
cells/infection). The first and the second sorted viral clones improved the signal from 






Figure 4.9 Permeability of the fluorophore. These pictures were taken before (left 
panel) and 2 minutes after (right panel) adding DFHBI-1T into the medium of TEds1x-
3’UTR1xSpinach2-infected BHK cells (MOI 5, 20 hours post infection, objective lens 
20x). After adding fluorophore at the 2
nd
 frame of time lapse (10 seconds/frame), the 
signal came up almost immediately and reached its plateau within few minutes. 
 







Figure 4.10 One-step viral growth curve. The growth curve showed lower infectious 
virions in supernatant from TEds2xSpinach2 (green)-infected cells than the others in both 
























Figure 4.11 Attenuation of the sorted viral clones occurs in vivo not in vitro. The 




 sorting had the comparable amount of virions in 
one-step viral growth to their parent, TEds-1Sp+1UTRSp, and the original TE strain in 
both BHK and dAP7 cells (MOI 5). However, at day 3 (the peak of viral replication in 
mouse brains), there was no detectable infectious virion from brain homogenate infected 
with 1a5, 1b6, and 1c6 from the 2
nd
 sorting, while the original TEds-1Sp+1UTRSp 








Figure 4.12 Gel electrophoresis shows unstable viral clones. (A) RT-PCR of RNA 
extracted from supernatant fluids of transfected or infected BHK cells showed 3 bands in 
TEds-2Sp PCR product (left panel). The largest band was the correct size, while the 
smallest band was the same size as TEds-1Sp. The TEds-1Sp+1UTRSp PCR product had 
2 bands (right panel). The larger was the correct size, while the smaller had a large 
deletion. All clones from the plaque purification had RNAs the same deletion. (B) 
Sequences from the RNA extracts of the viruses in the supernatant fluids of BHK cells 
infected with TEds-1Sp+1UTRSp or its sorted clones, starting from 2
nd
 subgenomic start 
to the last base before poly-A showed various point mutations in the sorted viruses (1
st
 
sorting – 1c9, 1d11, 2c9; 2
nd
 sorting – 1a5, 1b6). The sequence deleted from the smaller 
band shown in the gel electrophoresis is underlined. (Green characters – restriction sites, 







Figure 4.13 Viral RNA dynamics and cell-to-cell viral transmission. The time course 
of viral RNA replication differed from cell to cell. Spinach2 signals from 3 cells (A) were 
plotted against time. In the same time frame, viral replication had just begun, been in the 
middle, and reached the plateau in cell number 1, 2, and 3, respectively. Viral RNA was 
concentrated at the filopodial tip (white arrow) of an infected BHK cell at 4h (B). The tip 
adheres to the adjacent uninfected cell. The viral RNA was first detected in and then 
spread away from the adhesion site. (Time lapse imaging from 4 h after infection, MOI 
20, objective lens 63x, 30 seconds/frame) 
4h                          4½h                          5h                          5½h                          6h  
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Figure 4.14 Anti-E2 antibody increases intracellular viral RNA and fails to inhibit 
cell-to-cell transmission in BHK cells. At 6 h after infection of BHK cells (TEds-
1Sp+1UTRSp, MOI 5), more spinach2 signal was observed when treated (A, right panel) 
with anti-SV E2 (clone SV127, 1μg/ml) at 2 h after infection than untreated (A, left 
panel). When cells were infected at a low MOI (0.01), antibody failed to inhibit spread of 
virus to the adjacent cells as shown in time-lapse imaging (B) started at 24 h after 
infection. (objective lens 20x) 
 






Figure 4.15 Anti-E2 antibody clears intracellular viral RNA in undifferentiated 
neuronal cells. RNA in cAP7 cells infected with TEds-1Sp+1UTRSp (MOI=5) was 
imaged 20h after infection (green). Treatment with Dylight594-conjugated anti-SINV E2 
(red) at 1μg/ml decreased viral RNA within 4 h after treatment (16-20 hours post 
infection) (C). The effect of antibody on viral RNA was greater when treated 2 h after 
infection (D). (objective lens 20x) 
 





Figure 4.16 Spectral imaging can differentiate dim Spinach2 signal from high 
autofluorescence in differentiated neuronal cells. In dAP7 cells, dim Spinach2 signal 
overlapped with high autofluorescence in the usual channel mode (B, 1
st
 panel). The 
lambda mode (A), which recorded the emission spectra, showed the difference between 





 panels) separated the signal into 2 channels, Spinach2 represented 
by green color and autofluorescence represented by red color. Viral RNA was prominent 







Figure 4.17 Antibody-mediated viral RNA clearance in dAP7 cells is associated with 
antibody binding to the cell membrane. dAP7 cells infected with TEds-1Sp+1UTRSp, 
MOI 5, were treated with 1μg/ml of Dylight594-conjugated anti-SV E2 (clone SV127) at 
2 hours post infection. This picture (20 hours post infection, objective lens 63x, lambda 
mode) showed the amount of viral RNA (Spinach2 in green) was reversely correlated 
with the amount of the antibody (red) that bound to the cell membrane.  
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Figure 4.18 Signal intensities of all constructed viruses. The live-cell images 
(objective lens 20x) compare signal intensities of all viral constructs after adding DFHBI-
1T to the infected BHK cells (MOI = 5, 6 hours post infection). 
 131 
 
Figure 4.19 The effect of formaldehyde fixation on Broccoli signal. The images 
(objective lens 20x) show infected BHK cells (MOI = 5), fixed with 3.7% formaldehyde 
at 16 hours post infection. After adding DFHBI-1T, there is still Broccoli signal in the 
cells, infected with TEds6Br.  
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Figure 4.20 Colocalization between SINV RNA FISH and 
Broccoli. The images (objective lens 20x) show infected 
BHK cells (MOI = 5), fixed with 3.7% formaldehyde in PBS 
at 6 hours post infection. After adding DFHBI-1T, RNA 
FISH E1+E2 (red) colocalizes well with Broccoli-DFHBI-1T 
(green) signal in both TEUTR4Br and TEds10Br. The scatter plot (X – red, Y – green) 
shows strong colocalization (Rcolocalization = 0.9049). 
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Figure 4.21 Rare discrepancy between RNA FISH and Broccoli. The images 
(objective lens 63x) show TEds10Br-infected BHK cells (MOI = 5), fixed with 3.7% 
formaldehyde in PBS at 6 hours post infection. Though very rarely, some cells may have 
discrepancy between FISH and Broccoli signal (white arrow), resulting in a separated 
cluster in the scatter plot (X – red, Y – green).  
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Figure 4.22 Accumulation of viral RNA in foot processes. Live-cell imaging (objective 
lens 20x) has been taken in lambda mode (spectral imaging). TEds10Br-infected dAP7 
cells (MOI = 20, 24 hours post infection) accumulate viral RNA (green – Broccoli-
DFHBI-1T) at their filopodial tips (red arrow heads), which adhere to the uninfected cell 
(only yellow – autofluorescence). 
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Figure 4.23 Live-cell imaging in the infected mouse brain slice. The small inlet shows 
the TEds10Br-infected mouse brain 250-μm slice (3 days post infection) on glass-bottom 
of a 35-mm dish in imaging medium (DFHBI-1T). Live-cell imaging of the red square 
area on the brain slice (objective lens 20x, lambda mode) shows Broccoli-DFHBI-1T 
signal (green) in some cells along corpus callosum.
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Figure 4.24 One-step growth curve of SINV-Broccoli. The graphs show the amount of 
infectious virus in the supernatant fluids from BHK (A), cAP7 (B), or dAP7 (C) cells 
infected with various SINV-Broccoli recombinant viruses (3 replicates per virus per time 
point). (D) Amount of infectious virus in brain homogenates from mice at day 3 post 
infection with various SINV-Broccoli recombinant viruses (3-6 mice per virus)
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Figure 4.25 The distribution of SINV genomic and subgenomic RNA. Live-cell 
imaging (objective lens 63x) of infected BHK cells (MOI = 5, 16 hours post infection) 
shows more diffused distribution of viral RNA (green – Broccoli-DFHBI-1T) of 
TEds6Br (A), of which both genomic and subgenomic viral RNA are labeled with 
Broccoli. On the other hand, only genomic RNA is labeled with Broccoli in TEnsP3-4Br 
infection (B). SINV genomic RNA is accumulated in perinuclear area. 
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Figure 4.26 Vesicle-like arrangement of Sindbis 
viral genomic RNA. Live-cell imaging of 
TEds14Br-infected BHK cells (MOI = 5, 20 hours 
post infection) shows perinuclear vesicle-like 
arrangement of viral RNA (green – Broccoli-




Figure 4.27 Genomic RNA-associated structures. Live-cell imaging (objective lens 
63x) of TEds14Br-infected BHK cells (MOI = 5, 20 hours) shows the association 
between SINV genomic RNA, in vesicle-like arrangement, and SINV E2 protein (A) or 
mitochondria (B). A – Cells had been co-infected with the same amount of SINV TOTO 
E2-mCherry (a gift from Richard Kuhn, Purdue Institute for Inflammation, Immunology 




Figure 4.28 Accumulation of SINV genomic RNA at the perinuclear halo. Time-lapse 
live-cell imaging (objective lens 63x) of TEnsP3-8Br-infected BHK cells (MOI = 20, 4-6 
hours post infection) shows genomic RNA-associated vesicles/vacuoles (green) 
surrounding the perinuclear halo (most likely the Golgi apparatus). Then the new 
genomic RNA is increasingly accumulated and formed vesicle-like arrangement (red 




Figure 4.29 SINV RNA replication enhanced by higher MOI and antibody 
treatment. Time-lapse live-cell imaging (A, objective lens 20x) of TEUTR4Br-infected 
BHK cells (3-5.5 hours post infection) shows the effects of MOI (10 VS 100) and anti-E2 
[SV127] antibody treatment (5 μg/ml at 2 hours post infection) on the replication rate of 
viral RNA (green). The graph (B) shows the average signal intensity of the 5 brightest 
cells from each group (1 frame = 150 seconds). 
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Figure 4.30 Effect of antibody on viral RNA distribution. Live-cells imaging 
(objective lens 20x) compares the effect of antibody treatment (B) to no treatment (A) in 
TEnsP3-4Br-infected BHK cells (MOI = 20, 12 hours post infection). Without antibody 
treatment (A), the viral genomic RNA (green) is mainly accumulated around perinuclear 




Figure 4.31 Antibody- and IFN-γ-mediated SINV RNA clearance. Live-cell imaging 
(objective lens 20x, lambda mode) shows the effects of antibody and IFN-γ on viral RNA 
clearance in TEUTR4Br-infected dAP7 cells (MOI = 20) from 12 to 72 hours post 
infection (yellow – autofluorescence, green – Broccoli-DFHBI-1T, red – propidium 
iodide (dead cells)) . All treatments were applied at 2 hours post infection (TrkA control 
Ab 5 μg/ml, Anti-E2 [SV127] 5 μg/ml, rat IFN-γ 500 u/ml). The viral RNA begins to 
decrease at 24 hours. At 72 hours, viral RNA is mostly cleared, especially in the 
combined antibody-IFN-γ treatment. In contrast, most of the cells are dead and detached 
from the plate in no treatment and control antibody (TrkA) treatment groups. 
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Figure 4.32 Inverse correlation between the amount of intracellular viral RNA and 
antibody on the cell membrane. Live-cell imaging (objective lens 20x, lambda mode) 
shows the amount of viral RNA (green) in TEUTR4Br-infected dAP7 (MOI = 20, 24 
hours post infection), treated with 1 μg/ml of SV127-Dylight594 at 2 hours post 
infection. The cells that have antibody (red) bound to their membranes (white arrows) can 
clear the viral RNA, while the cells that lack antibody on their membrane cannot.  
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Figure 4.33 Lack of envelope protein on the surface of some SINV-infected cells. 
dAP7 cells infected with SINV TOTO E2-mCherry (MOI = 20), followed by anti-E2 
[SV127, 5 μg/ml] treatment at 2 hours post infection, were fixed with 3.7% formaldehyde 
at 24 hours. Being stained with anti-mouse IgG (green), E2 protein (red) appears on the 
membrane of the cell that antibody (green) can bind (white arrows). In contrast, antibody 
cannot bind another cell that has only intracellular E2 (red arrows). 
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Figure 4.34 The effects of antibody and IFN-γ on viral clearance and cell survival in 
dAP7 cells. The flow cytometry histograms show the Broccoli-DFHBI-1T signal in 
dAP7 cells, infected with TEds10Br (MOI = 20). A – the signal intensity of infected cells 
at 24 (blue) and 48 (red) hours after infection still overlaps with autofluorescence (gray). 
The numbers of Broccoli+ cells at 24 hours (B) and 48 hours (C) after treatment with or 
without antibody and IFN-γ at 2 hours post infection are summarized as a bar chart (D), 
showing that both antibody and IFN-γ can mediated viral RNA clearance. E – a bar chart 
shows the effect of treatments on cell survival. Both SV127 and IFN-γ improve survival 
in dAP7 cells. 
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Figure 4.35 The effects of antibody and IFN-γ on viral clearance and cell survival in 
BHK and cAP7 cells. The flow cytometry histograms show the Broccoli-DFHBI-1T 
signal in cells, infected with TEds10Br (MOI = 20). The numbers of Broccoli+ cells in 
BHK (A) and cAP7 (B) cells after treatment with or without antibody and IFN-γ at 2 
hours post infection are summarized as a bar chart (C). D – a bar chart shows the effect of 
treatments on cell survival. None of the treatments improve survival in both cells, while 






Despite growing evidence, the persistence of typical RNA viruses is not  well-
known to physicians, scientists, or even virologists. So far, most studies mention the 
persistence just from RT-PCR of a small specific viral gene fragment. Our study aimed to 
find more complete answers to this enigma.   
Significance of routes of infection  
 Intracerebral inoculation is probably not an appropriate route of infection for 
experiments, because it is not natural and can cause 2 distribution patterns, which are 
opposite to each other (Chapter 2). However, it did allow us to determine that there is no 
specific set of cells for viral persistence. SINV will persist in oligodendrocytes, if the 
infection begins in the white matter. On the other hand, SINV will persist in neurons, if 
the infection begins in the gray matter. Studies of SINV encephalitis usually assume that 
infection and clearance mainly occur in neurons. These previous studies used 
intracerebral inoculation and need to take into consideration the possibility of infection in 
oligodendrocytes. 
There is no obvious difference in virus persistence between white and gray matter 
tropisms, detected by plaque assay, SINV RT-qPCR, and anti-SINV ELISA. However, in 
assessment of morbidity and mortality, this can be a confounding factor, but it is 
impossible to know the distribution pattern in a mouse without examining the brain. 
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Therefore, intranasal inoculation, which always affects gray matter, may provide more 
consistent results. 
Naturally, SINV is transmitted by mosquito bites, so subcutaneous inoculation is 
probably the most relevant, but entry into the CNS may not occur reliably. SINV-specific 
antibody is found in plasma 2-4 days before it is found in the brain (Chapter 3), despite 
the fact that the primary site of infection is the brain after intracerebral inoculation. Hosts 
may have the best outcome after subcutaneous inoculation, which takes multiple steps 
before the virus can reach CNS (Figure 1.4). In IFN-α/β receptor-deficient mice (A129) 
infected with low virulent SINV (TOTO 1101), weanling mice died 2 days later after 
subcutaneous inoculation than after intracerebral inoculation, and adult mice survived 
subcutaneous, but not intracerebral inoculation (Figure 5.1) (23). Thus, study results 
likely depend on route of infection. 
Intracerebral inoculation may resemble rabies virus infection, which hides itself 
from the immune response until it reaches the CNS (119), while intranasal inoculation 
may resemble influenza virus encephalitis, in which the infection originates from the 
nasal mucosa (120). 
Longer detection of Sindbis viral proteins than viral RNA 
 Viral proteins were found in more cells than viral RNA after the clearance of 
infectious virus. Viral proteins were also found in apoptotic cells and in the phagosomes 
of macrophages. During optimization of the brain slice culture, it became apparent that 
during prolonged culture of a 300-μm-brain slice, most of the cells die, resulting in only 
about 5 ng of RNA per slice, compared to 100 ng in a fresh brain slice. However, 
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antibody staining can still detect a lot of viral proteins in a degraded brain slice. 
Furthermore, in SINV-Broccoli-infected BHK cells, we observed a rapid loss of Broccoli 
signal just before propidium iodide entered the cells. This means that the viral RNA is 
degraded or loses its secondary structure even before the cell loses integrity of its plasma 
membrane.  
Persistence mechanisms of SINV 
 Both SINV viral RNA and proteins can be detected with RNA FISH and IF, 
respectively, for at least 1 month after infection, when IFN-γ and SINV-specific antibody 
levels are high. This is similar to subacute sclerosing panencephalitis (SSPE), a disease in 
which measles virus (MV) is propagated in the the brain in the presence of very high 
levels of anti-measles antibody in the brain (63, 121). 
 How can SINV evade antibody-mediated clearance? The most straightforward 
answer would be selection of escape mutants. However, in adoptive antibody transfer 
model, the reactivated virus recovered from SCID mice after the antibody level dropped 
can still be neutralized by the original antibody (66). This makes escape mutants as a 
mechanism less likely, but still possible, because we cannot exclude the reversion of 
mutants into WT.  
 The timing of antibody production or treatment might also be important. In SINV-
Broccoli-infected dAP7 cells, anti-E2 antibody treatment is effective for viral RNA 
clearance when applied 2-4 hours after infection, but not at 12 hours (data not shown). 
SINV induced host translation shut-off (44) might cause the failure of clearance with late 
antibody treatment. However, in other models, antibody treatment can successfully clear 
 152 
the virus when applied even later; 24 hours for AT3-bcl-2 cells (87, 88), 2 days for dorsal 
root ganglion neurons (85), 7 days for SCID mouse brains (66, 85). The differences in 
viral strains, multiplicity of infection (MOI), cell types, and the presence of other aspects 
of the immune response are possibly responsible for the different results. In dAP7 cells, 
even treating with antibody as early as 2 hours post infection, SINV RNA can still persist 
in some cells (Figure 4.31).  
  The evidence from FISH/IF shows that antibody is not detected on the surface of 
infected cells even at the time points (day 10 onward) when we can detected SINV-
specific antibody in brain homogenates by ELISA. By incubating SINV-infected BHK 
cells with a diluted brain homogenate, we can detect antibody heavily bound to the cell 
surface with immunofluorescence. Thus, SINV-specific antibody is definitely present in 
brains and capable of binding infected cells in vitro, but cannot bind the surface of 
persistently infected cells in mouse brains. In dAP7 cells infected with either SINV-
Broccoli or SINV-Spinach2, antibody treatment clears viral RNA in all cells, except the 
ones that antibody cannot bind to. 
After clearance of infectious virus (D7-10), immunofluorescence shows that 
persistently infected cells in brains either do not express SINV E2 protein on the cell 
membrane or do not express it at all. The total loss of SINV E2 expression can be 
explained by the results from long-range PCR, which shows large deletions in the E2 
gene by day 14 after infection. A few cells in the brain still have SINV E2 protein 
intracellularly, but not on the surface. dAP7 cells to which anti-E2 antibody cannot bind 
also have SINV E2 protein intracellularly, but not on the surface. Mutations in some 
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regions of E2 can inhibit transportation of E2 to plasma membrane, even though E2 
production is comparable to that of WT (Figure 5.2) (122).  
 How can SINV evade IFN-γ clearance? In SINV-Broccoli-infected dAP7 cells, 
IFN-γ treatment is effective for viral RNA clearance applied at 2-4 hours after infection, 
but not at 12 hours (data not shown). SINV induced host translation shut-off (44) might 
cause the failure of clearance with late IFN-γ treatment. However, in other models, IFN-γ 
treatment can successfully clear or reduce the virus when applied even later; 24 hours for 
both dCSM14.1 cells (29, 48) and dorsal root ganglion neurons (48). For dNSC34 cells, 
IFN-γ treatment at 2-5 hours shows clear benefit, while treatment at 24 hours results in 
only marginal improvement (12). In previous study, dAP7 cells treated with IFN-γ at 24 
hours still cleared the virus with excellent survival (48). Our study with SINV-Broccoli 
fails to replicate these results even when IFN-γ treatment was applied at 12 hours. 
Different virus strains and MOIs (=1 in previous study) might be the reason.  
dAP7 cells are very resistant to SINV replication and inefficiently infected (28). 
By Poisson distribution, MOI of 5 should get more than 99% cells infected, if 1 virion is 
enough to infect 1 cell. However, unlike BHK cells, MOI of 5 is not enough to infect 
most of the dAP7 cells even in the unattenuated SINV-Broccoli clones (TEUTR4Br and 
TEds6Br) that give higher titer of infectious virus than SINV TE both in vitro and in vivo. 
At an MOI of 20, which we used for our study, more than 90% of dAP7 cells are infected 
at 12 and 24 hours. The most attenuated clone, TEds14Br, infects less than 1% of dAP7 
cells even at an MOI of 20. This indicates that 1 virion might not be enough for some 
dAP7 cells. Thus, the results of previous studies that used a less virulent SINV and low 
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MOI must be interpreted carefully, because most of these differentiated neuronal cells 
may not be infected.  
In BHK cells infected with SINV-Broccoli, it is clear that viral replication is 
faster with a higher MOI. This might possibly be true for dAP7 cells, where high MOI is 
needed for virus to replicate fast enough to shut down dAP7 innate cellular response. 
Unfortunately, the poor Broccoli signal and slow viral replication in dAP7 cells make it 
hard to repeat the experiment in dAP7 cells. The same explanation might also apply to 
why SINV persists in a few dAP7 cells even when IFN-γ treatment is as early as 2 hours 
post infection. There will be a small percentage of cells that are infected by more virions 
than average, which might lead to viral replication that is fast enough to suppress the 
cellular response to IFN-γ. On the other hand, it might be simply that some cells may 
express lower levels of IFN-γ receptors or have a defect in this signaling pathway (e.g. 
STAT). Using FACS, it is possible to separate the high Broccoli signal in persistently 
infected cells from the low Broccoli signal in cells that successfully clear the virus. Then 
comparisons (by e.g. microarray, reverse phase protein microarray, Western blot, etc.) 
between these 2 groups of cells can be done to provide some clues on what determines 
the fate of these cells. 
The nature of persistent SINV RNA 
 Persistent SINV RNA is mainly incomplete subgenomic RNA. Some of this 
persistent subgenomic RNA still has a poly-A tail, but has lost the E2 gene by deletion. 
The lack of the E2 gene makes it unlikely to spread to new cells. The large deletion in the 
E2 gene, detected by long-range RT-PCR with an oligo-dT primer, contradicts the 
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detection of a lot of E2 gene at the same time points by RNA FISH E2 gene and RT-
qPCR that targets a short sequence within E2 gene. This means both RNA FISH and RT-
qPCR detect the E2 gene in the viral RNA fragments that lack a poly-A tail. Cellular 
RNases might cause the fragmentation of viral RNA. 
 The large deletions are about 2000 nucleotides, about half size of the subgenomic 
RNA. The size of the remaining subgenomic RNA is similar to the SINV 20S defective 
interfering particle (DI) RNA (123). Though the sequence itself might be able to replicate, 
the lack of intact genomic RNA for translation of the replicase proteins makes it unlikely 
to replicate. Alphavirus DI RNAs are usually generated in vitro with few in vivo reports. 
For example, an avirulent strain (A7) of Semliki Forest virus (SFV) can form DI RNAs in 
mouse brains on day 4 after peritoneal inoculation (124).  
 These SINV RNAs with large deletions of E2 gene might still produce capsid 
protein, because RNA-FISH-positive cells frequently lack E2 proteins, but always have 
capsid proteins inside. However, our set of primers covers E3-E2-6K-E1, but not capsid. 
Thus, we cannot exclude the possibility that there might be multiple deletions in the same 
RNA. 
 Interestingly, in a model of mouse chronic inflammatory myopathy, 
coxsackievirus RNA persists in muscle at 1 month after infection in the form of dsRNA 
(Figure 5.3). Moreover, the persistent RNA is an intact complete genome without 
mutation (125). Because our study focuses on the viral RNA persistence during the 2
nd
 
phase of clearance (gradual decrease in viral RNA), the unexplored nature of persistent 
viral RNA in the 3
rd
 phase (sustained low level viral RNA) might still be dsRNA. 
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 The fact that SINV viral RNA during clearance has so many forms (genomic, 
subgenomic, minus, dsRNA, deletion/defective, fragments, etc.) poses a challenge for the 
definition of viral RNA clearance. The degradation ranges from a single cleavage, which 
is probably enough to make viral RNA lose function, to complete degradation of viral 
RNA. The former is likely to be much faster than the latter. Our RT-qPCR covers only 74 
nucleotides in the E2 gene (8732-8805). If we expand the size of the region covered by 
RT-PCR, the results of RNA clearance by different immunoglobulin-deficient mice in 
Chapter 3 may not be the same.  
Synergism and redundancy of antibody and IFN-γ-mediated SINV clearance 
 In previous in vitro studies, responses of infected cells to anti-E2 antibody are 
quite similar to IFN-γ. Both treatments increase viral replication early on before 
restoration of host functions and later suppression of the replication (29, 88). Our study in 
SINV-Broccoli-infected dAP7 also shows similarity between the 2 treatments. Both are 
effective at 2 hours after infection, but not at 12 hours. Both show the same time frame of 
clearance, though antibody is better in both viral RNA clearance and survival 
improvement than IFN-γ. Combined treatments do not speed up the clearance, but 
increase the number of cells that respond. This suggests that both treatments might 
partially share the same pathway responsible for clearance and survival. For instance, 
both treatments are known to potentiate the type-I IFN response (87, 126-128) 
 The study of SINV-Broccoli supports the mouse model results. Both IFN-γ and 
antibody are effective and synergistic. In brains, where infectious virus titer is very high, 
antibody is better than IFN-γ. In spinal cords, where infectious virus titer is quite low, 
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both treatments are equal. If the virus is attenuated (e.g. TEds10Br), then antibody might 
not be needed even in brains.  
Viral clearance in DKO mice (no secreted antibody) in our study is similar to 
μMT mice (no B-cell) in previous studies (43, 45). However, a direct comparison 
between DKO and μMT mice would be interesting, because B-cells themselves might 
contribute to the viral clearance by functions in addition to secreting antibody. The role 
of the adaptive immune response in viral clearance from mouse CNS is summarized in 
Table 5.1. 
Table 5.1 Summary of mouse models used in SINV clearance studies (SC – spinal cord, 
P – persistent, C – clear, NA – not available) 
Mice T-cell IFN-γ B-cell IgM IgG Brains SC 
SCID (43, 45, 85) - + - - - P P 
Athymic nude (90, 
129) 
- + + + - C NA 
μMT (43, 45) + + - - - P C 
IFN-γ-/- (43, 47) + - + + + C C 
μMT IFN-γ-/- (43) + - - - - P P 
AID-/- + + + + - C C 
sIgM-/- + + + - + C C 




Problem with mouse models 
The mice from the 4 antibody-knockout mouse groups are clearly different in 
weight. The heaviest mice are sIgM-/-, followed by WT, DKO, and AID-/- mice, 
respectively. Previously, we had done the same morbidity-mortality experiments (as in 
Chapter 3) to compare the outcomes of 24 WT mice versus 24 AID-/- mice and then also 
24 WT mice versus 31 sIgM-/- mice, where AID-/- had the worst and sIgM had the best 
outcomes. The differences were quite remarkable. However, when we finished breeding 
the DKO (AID-/- sIgM-/-) mice and repeated another 2 independent experiments 
(Chapter 3) with all 4 groups of mice (WT, AID-/-, sIgM-/-, DKO), the differences were 
gone.  
All AID-/- and sIgM-/- mice from the 1
st
 round of experiments were the F2-3 
generations of AID+/- mice from Albert Einstein College of Medicine and sIgM+/- mice 
from University of California, Davis, while WT C57BL/6 mice were from Jackson 
Laboratory. There have been studies that have shown that mice with the same genetic 
background but from different facilities/vendors have different gene expressions and 
microbiomes (130), which result in differential susceptibility to some pathogens, e.g. 
Plasmodium yoelii (131) and Burkholderia thailandensis (132). The latter example 
reveals the amazing role of microbiome. E. coli O21:H
+
 found in C57BL/6 mice from 
University of California, Berkeley, but not from Jackson Laboratory, can translocate from 
the intestine to colonize adipose tissues and activate the inflammasome, resulting in the 
release of IGF-1 which prevents muscle wasting induced by B. thailandensis (132). When 
we conducted the 1
st
 experiment, our mice might not have adjusted their microbiome to 
the new environment, resulting in the different outcomes. 
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Even with the same genetics, mice can still have largely different microbiomes. It 
would be surprising if immuno-deficient mice did not have microbiome different from 
wild type mice. Indeed, AID-/- mice, which lack IgA in guts, have 100-fold expansion of 
anaerobes in the small intestine (21). The intestinal epithelium up-regulates interferon 
and suppresses GATA4-related functions, leading to fat malabsorption and low fat 
deposit (133). This might explain why AID-/- mice have the lowest body weight. 
Antibiotic treatment or IgA restoration, which decreases these bacteria, can reverse 
lymphoid hyperplasia and germinal center enlargement, typical phenotypes found in 
AID-/- mice (134, 135). DKO mice suffered the same fate (133). This complicates the 
interpretation of the results of most experiments involving immuno-deficient animals 
where the effect may be caused by the deficiency per se or by specific microbiome-
induced immune response. 
Regarding effects of the microbiome on immune responses and outcomes after 
experimental infection, which approach would be the best to understand the function of 
immune-related gene that is deficient in the knockout mice? We have to choose between 
germ-free, artificial colonization of specific pathogen free flora (130), shared microbiome 
(e.g. co-housing), or signature microbiome. As for the signature microbiome that would 
be specific to each type of immuno-deficient mice, we do not yet know how many 
generations it takes to reach equilibrium, if the environment remains unchanged.  
For example, in AID-/- mice, the transition would begin with the 1
st
 generation of 
homozygous AID-/- mice, of which microbiome is transferred from their 
immunocompetent heterozygous AID+/- parents. These AID-/- pups are also surrounded 
by their competent siblings (AID+/+ or AID+/-). Furthermore, though the AID-/- pups 
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cannot produce IgG or IgA by themselves, they acquire IgA through milk and IgG 
through placenta. It is very unlikely that these first-generation AID-/- mice will reach 
their own signature microbiome early on. These mice will then pass their microbiome to 
their next generation. Therefore, the mice in our 1
st
 morbidity-mortality experiment might 




experiments, a year after the 1
st
, had probably acquired their signature microbiome, 
resulting in a difference in the results. Due to the mouse housing cost, most investigators 
probably conduct the experiments as soon as there are enough mice. This might be 
problematic if the microbiome does affect the experiment. 
In conclusion, SINV RNA and proteins persist long after clearance of infectious 
virus from the mouse CNS. SINV E2 gene deletion helps the virus evade antibody-
mediated clearance. As a result, antibody may not be necessary for the 2
nd
-phase of viral 
RNA clearance from the mouse CNS, even though antibody is very effective in vitro and 
in adoptive transfer models. In the presence of T-cells and IFN-γ, the main advantage of 
having antibody in SINV encephalomyelitis is the suppression of viral reactivation, not 
the clearance of viral RNA. Our study emphasizes the flexibility and reserve power of the 
immune system. A deficiency in one aspect can be replaced with another, and all aspects 
are needed only when the burden of infection is very high. 
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Figure 5.1 Survival rate of A129 mice infected with SINV TOTO 1101 (low virulent) in 
different age groups and inoculum sites (23). 
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Figure 5.2 Functional regions of Sindbis virus E2 protein, characterized from insertional 
transposon mutagenesis of E2 gene. Each color represents plaque size of mutant viruses. 
Blue – large (wild-type-like), green – medium, brown – small, red – lethal (122). 
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Figure 5.3 A – Control viral RNAs (+, -, double stranded) were generated by in vitro 
transcription and amplified by strand-specific (+ or -) RT-PCR with or without RNase I 
digestion of single-stranded RNA. B – Coxsackievirus (MP1) infection in mouse muscle 
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